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ABSTRACT

It is estimated that five million workers throughout the United States of America rely
on Respiratory Protective Devices (RPDs) to protect their health. However, there are
a number of factors that limit the wear time of RPDs in the workplace. This includes
high breathing resistance, interference with vision, heat stress, difficulty
communicating and re-breathing of carbon dioxide (CO2). Of these factors there has
been little research into the adverse affects to CO2 re-breathing in RPDs. CO2 is
known to stimulate respiration, increase heart rate, dilate blood vessels and in higher
concentrations produces symptoms of discomfort, anxiety, headache, fatigue,
dizziness and shortness of breath. Previous investigations on CO2 re-breathing are
limited by small sample size and have not evaluated the relationship between CO 2
inhalation and phonic respiration (breathing during speech) in RPDs. This research
was conducted in two parts, a pilot study at the University of Wollongong, New
South Wales and a field study at a worksite in Mount Isa, Queensland. Participants
took part in a graded exercise test on a bicycle ergonometer that increased in
resistance every five minutes. During the third minute of each stage participants read
aloud a prepared text. Measures of expired CO2 (PECO2), inspired CO2 (PICO2) and
respiration were monitored. The results showed phonic respiration and low work
rates contributed to significantly higher levels of CO2 re-breathing. Aiming to reduce
CO2 re-breathing may result in improved wear time of RPDs. It is recommended that
these findings be incorporated in technical specifications regarding human factors for
RPDs.
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TERMS AND DEFINITIONS

Anaerobic (Exercise): Short “rapid” duration exercise that is powered by metabolic
pathways that do not use oxygen, e.g. sprinting
Carbon Dioxide (CO2): Gaseous product of aerobic respiration
Chemoreceptor: A sensory receptor that is activated by binding of a chemical
substance
Dead Space: Those portions of the respiratory system that do not exchange gases
with the blood
Dyspnoea: A subjective feeling of not being able to breathe or get air
End Tidal Carbon Dioxide (PETCO2): The concentration of CO2 at the end of
exhalation. Comparable to alveolar CO2
Hypercapnia (Hypercarbia): Elevated concentration of CO2 in the blood
Hyperventilation: An increase in alveolar respiration that is not associated with an
increase in metabolic rate
Hypoventilation: A decrease in alveolar respiration without a change in metabolic
rate
Minute Ventilation (VE or VI): The volume of air expired (or inspired) in one
minute
Peak Inspiratory Air Flow (PIAF): Highest flow rate that occurs during inhalation
(L min-1)
Partial Pressure: The pressure of a single gas
Respiratory Acidosis: Acidosis due to retention of CO2
Respiration: Exchange of gases between the atmosphere and the cells
Respiratory System: Those structures involved in respiration and gas exchange
Tidal Volume (VT):

The amount of exhaled (or inhaled) air during normal

respiration
Work of Breathing (WOB):

The effort required to inspire into the lungs
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ABBREVIATIONS

ACSM:

American College of Sports Medicine

ADU:

Dubois body surface area

AS/NZS:

Australian & New Zealand standard

BIPAP:

Bi-level positive airway pressure

BP:

Blood pressure, millilitres of mercury

BTPS:

Body temperature, ambient pressure, saturated with water vapour

CE:

Conformité Européenne meaning Eurpoean Conformity

CO2:

Carbon dioxide

ECF:

Extracellular Fluid

ECG:

Electrocardiogram

EN:

European standard

FEV1:

Forced expiratory volume in one second

:

Breathing rate, breaths per minute

FVC:

Forced vital capacity, litres

HR:

Heart rate, beats per minute

IDF:

Israel Defence Force

ISO:

International Organisation for Standardisation

JIS:

Japanese Industrial Standards

MBS:

Modified Borg scale

NASA:

National Aeronautics and Space Administration

NIOSH:

National Institute for Occupational Safety and Health

OSHA:

Occupational Safety and Health Administration

PACO2:

Alveolar partial pressure of carbon dioxide

PaCO2:

Arterial partial pressure of carbon dioxide

PAPR:

Powered air purifying respirator

PCO2:

Partial pressure of carbon dioxide

PECO2:

Percentage of expired carbon dioxide

PETCO2:

Partial pressure of end tidal carbon dioxide

PICO2:

Percentage of inspired carbon dioxide
vii

PIAF:

Peak inspiratory air flow, litres

PIS:

Participant information sheet

ppm:

Parts per million

RPD:

Respiratory protective device

rpm:

Revolutions per minute

SCBA:

Self contained breathing apparatus

VE:

Minute ventilation (expired), litres

VI:

Minute ventilation (inspired), litres

O2 :

Volume of oxygen uptake per minute, litres per minute
:

W:

Maximal oxygen uptake, millilitres per minute per kilogram
Watts
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1 INTRODUCTION

Respiratory protective devices (RPDs) are used in many environments to prevent the
wearer from inhaling hazardous substances in the atmosphere, for example, gases,
cement dust, welding fumes and bushfire smoke. According to the Occupational
Safety and Health Administration (OSHA) approximately five million workers
throughout the United States of America rely on RPDs to protect their health (OSHA
2011). However, according to a workplace survey by Laird et al. (1993) almost two
thirds of the respondents stated they removed their RPD for some reason before they
completed the work that required its use. The problem here is that if a RPD is
removed in an area where protection is required, even for a short period of time,
contaminants can enter the workers lung with adverse health effects. Therefore, it is
important to research factors that limit RPD wear time to assist in resolving this
problem.
There are a number of factors that limit the wear time of RPDs. This includes
high breathing resistance, interference with vision, difficulty communicating, heat
stress and facial discomfort (AS/NZS 1715: 2009). Research in the past has been
heavily focused on evaluating these problems, although some studies such as Kloos
and Lamonica (1966), Love et al. (1979) and Harber et al. (1982) have also examined
the physiological stress of carbon dioxide (CO2) re-breathing in RPDs.
CO2 re-breathing occurs from inhaling expired air that gets trapped in the
RPD, the amount of which is relative to the volume of the RPD (dead space). This
can cause an increase in the arterial concentration of CO2 (PaCO2), also known as
hypercapnia or hypercarbia, which can promote wearer discomfort. High PaCO2 has
been associated with symptoms of discomfort, fatigue, dizziness, headache, shortness
of breath, muscular weakness, ringing in the ears and drowsiness (Kloos and
Lamonica 1966).
The adverse affects of CO2 re-breathing in RPDs has been known for some
time. One of the earliest studies in this area was by Kloos and Lamonica (1966) who
studied methods of measuring inspired CO2 and its effect on breathing in RPDs.
Consequently there are a number of standards established for the design of RPDs that
1

specify maximum allowable CO2 concentrations in inhaled air.

However, the

understanding of the level of CO2 re-breathing that occurs in RPDs and its impact on
human wearers is limited. The reason for this lack of awareness may be due to CO2
being an invisible problem and other issues such as, the effects of heat stress, being
more recognisable.
A comprehensive review by Williams (2010) on physiological responses and
limitations of CO2 in RPDs found that exhaled CO 2 is not completely removed in the
breathing space of RPDs and that more research in this area was warranted. Factors
such as RPD type, size of person and exercise workload (increased metabolic CO 2)
were identified as having probable effects on CO2 re-breathing (Williams 2010). For
instance, it appears than an increase in exercise workload may increase the chance of
CO2 re-breathing.
In regards to RPDs, the models available are extensive. There are two main
types; air purifying respirators (APRs) and air supplying RPDs. Within this, APRs
mainly include particulate or gas and vapour removing masks, powered or nonpowered, half or full face masks. Whereas air supplied RPDs can include self
contained breathing apparatus’s (SCBA) and airline RPDs. In a review of 15 studies
on the effects of CO2 in RPDs (refer to Appendix A) less than half were on nonpowered APRs. Even less research assessed CO2 concentration in full face masks or
how this problem may impact the wearer adversely. This research is concerned with
CO2 re-breathing in full face RPDs.
Moreover, the affect of phonic respiration, our breathing during speech, on
CO2 levels in RPDs has not previously been evaluated. Phonic respiration occurs
primarily during exhalation and as a result decreases inhalation time (ISO/TS 169761: 2007). According to Boron and Boulpaep (2003) following the cessation of
speech

can increase by 25% and alveolar CO2 (PACO2) falls. Doust and Patrick

(1981) proposed that hypercapnia could explain the above increase in respiration
observed at the end of a speech. Many studies have focused on the impact of speech
on air flow rate and respiratory minute volumes (Silverman et al. 1943, Berndtsson
2004 and Holmer, Kuklane and Gao 2007). However, there is little research in the
literature on the influence of speech on CO2 concentrations in RPDs.

2

1.1

Key Research Questions

The aim of this research was threefold;


To determine the level of CO2 re-breathed in a full face RPD during low to
moderate intensity work.



Evaluate the impact of phonic respiration (breathing during speech) on CO 2
re-breathing in RPDs.



To examine if there was any association between other factors such as,
body surface area (BSA) and gender on CO2 re-breathing in RPDs.

1.2

Significance of the Study

In order to better understand CO2 re-breathing, the invisible problem in regards to
RPD use, this research aimed to address “how much CO2 re-breathing occurs in a full
face RPD?” Although many occupations require RPDs and communication in the
workplace, it is not known if speech influences CO2 re-breathing and if this is
associated with symptoms of hypercapnia. An exercise assessment would allow for
the assessment of whether CO2 re-breathing is affected with increased workload.
The measurement of dyspnoea is critical as this is one of the key causes of RPD non
wear and also impacts the wearers work capacity.
For these reasons, this research focused on the level of CO2 re-breathed in a
full face RPD while the wearer performed work (exercise on a bicycle ergonometer).
To our knowledge this is the first study to assess CO2 re-breathing during both
conditions of speech and no speech. Inclusion criteria for the study included workers
familiar to wearing RPDs. Also a large sample size was selected for this study as it
provided an opportunity to explore issues, for example the impact of BSA, which
other studies have been too small to support.
Greater understanding of this research area will assist manufacturers in
improving the design of RPDs so that they are more suited to the physiological
3

responses of the wearer. This will lead to increased wear time of RPDs with the
outcome of improved respiratory protection in hazardous environments.

1.3

Research Hypothesis

Following a review of the literature and a pilot study it was hypothesised:


Hypothesis one: There shall be a difference in CO2 re-breathing in RPDs
during periods of phonic respiration (breathing during speech).



Hypothesis two: There shall be a difference in CO2 re-breathing in RPDs
at increased exercise workloads.

1.4

Limitations of the Study

There are a number of factors that limit this study. They are as follows:


This study was limited in the amount of time and access to complete the
exercise assessments at the worksite. Data collection for the field study was
limited to five days. As a result participants did not have the opportunity to
get used to, or train riding the bicycle ergonometer.



There was an under representation of women in the sample, although a low
percentage of women in the mining industry is customary. In addition the
sample was mainly aged under 39 (68%).



The mode of exercise chosen (bicycle ergonomter) often imposes lower limb
fatigue which limits participants exercise capacity.



The worksite was deliberately selected for the study as the workers were
familiar with the use of full-face RPDs.

Therefore, it is possible these

workers sensitivity to CO2 is diminished.


Due to a lack of medical supervision, the level of CO2 during maximal
exercise was not assessed. Only low to moderate workloads were assessed.
4

1.5

Constraints of the Study

To make this study more manageable the following constraints were made:


The field study aimed to collect data from 40 participants.

This was

calculated to be a manageable size.


The study investigated dyspnoea (MBS), respiratory rate ( ) and peak
inspiratory air flow (PIAF). Other well known respiratory variables such as
respiratory quotient (RQ), work of breathing (WOB), minute ventilation (V E)
and tidal volume (VT) was excluded from analysis.



The field study was restricted to workers familiar with the use of RPDs.



In addition, only one level of breathing resistance was imposed on workers.
Therefore, if higher resistance had been used, even larger concentrations of
CO2 may have been measured.

1.6

Statement of Assumptions

There were some unavoidable assumptions made in this study.

These were as

follows:


Indoor (atmospheric) CO2 was considered constant and to not contribute the
level of CO2 inhaled by the wearer.



Oxygen uptake (

) was calculated using the leg cycling equation

recommended by American College of Sports Medicine (ACSM) (2006). It
was assumed that

was the same during both conditions of speech and no

speech, with and without the RPD. However there is evidence that working
with RPDs reduces total energy expenditure and


(Carretti et al. 2001).

That the device used is representative of full face RPDs used in the
workplace.

5

2 REVIEW OF THE LITERATURE

A review of the literature on the physiological effects of CO2 and the implications
this has in regards to RPDs was conducted. In addition methods used for evaluating
CO2 in RPDs and what factors may impact the results is also described. At the end of
this section research recommendations for the pilot and field study are made.

2.1

Introduction

The aim of this research is to determine how the level of CO 2 re-breathed in RPDs
impacts the wearer, especially in regards to their respiratory responses. It is thought
that increased CO2 re-breathing while wearing the device contributes to dyspnoea and
may impact the wear time of the RPD. More research on this problem will provide
information to assist in the design of RPDs that are more suited to the physiological
responses of the wearer. This will assist in improving comfort of RPDs and increase
respiratory protection in hazardous environments.

2.2

Physiological Effects of Carbon Dioxide

CO2 is a “by-product of respiration” and is present in the atmosphere at very low
levels (0.03% or 300 ppm) (ISO/TS 16976-3: 2011). At this level it has minimal
physiological consequences and does not impair our day to day function. However,
elevated CO2 in the environment, such as in the dead space of RPDs, can have a
significant impact on the respiratory system (ISO/TS 16976-3: 2011).
At rest “the chemical state of the blood exerts the greatest control of
pulmonary respiration” (McArdle, Katch and Katch 2001).

Changes in CO 2

concentration stimulate neural receptors (chemoreceptors) in the arterial system
6

which initiates changes to respiration. According to the International Organisation
for Standardization (ISO) CO2 is about 20-25 times more soluble in the blood than
oxygen (O2) (ISO/TS 16976-3 (2011). Therefore, it is not surprising that small
changes in CO2 concentration can have a powerful affect. For example, resting
respiration doubles when PaCO2 in humans increases to just 1.7 mmHg (0.22%) in
inspired air (McArdle, Katch and Katch 2001). This is due to changes in blood
acidity which is relative to the CO2 content of the blood. A fall in blood pH
(acidosis) is the result of CO2 accumulation in the blood (McArdle, Katch and Katch
2001). This signals increased respiration to eliminate CO 2 from the blood to the
alveoli.
CO2 is removed from the blood to the alveoli by process of diffusion due to
differences in partial pressures (McArdle, Katch and Katch 2001). For example, CO2
is measured at 0.03% in atmospheric air (ISO/TS 16976-3: 2011). At sea level
(where the atmospheric pressure is 100 kPa or 760 mmHg) this means the partial
pressure of CO2 is 0.03% x 100 kPa, equal to 0.03 kPa. The concentration of CO 2 in
the alveolar air is 5.3%, giving a partial pressure of 5.3 kPa (ISO/TS 16976-3: 2011).
The partial pressure of CO2 in the blood stream is 6 kPa higher than alveolar air
(ISO/TS 16976-3: 2011). As a result CO2 moves down the partial pressure gradient
from blood, to alveoli and is eventually breathed out.
Alternatively CO2 retention can occur in the body if the level of CO2 in the
atmosphere (such as dead space in RPDs) exceeds the alveolar concentration. Figure
2.1 illustrates the acute effects of increased PaCO2.
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Increased arterial PCO2

Increased PCO2 decreases pH in brain extracellular fluid (ECF)

Peripheral chemoreceptors in carotid
and aortic bodies (mediate 30% of the
CO2 response)

Central chemorecptors in medulla respond to
H+ in brain ECF (mediate 70% of the CO2
response)

Medullary respiratory centres
Respiratory muscle
Increased ventilation (more CO2 exhaled)

Decreased arterial PCO2

Figure 2.1 Mechanism by which increased arterial carbon dioxide regulates
ventilation by Marieb and Hoehn 2010

2.2.1 Hypercapnia
High levels of inspired CO2 (PICO2) generally results in hypercapnia, when PaCO2 is
elevated above the normal range (4.5 kPa or >45 mmHg) leading to a blood pH of
<7.38 (Silverthorn 2004). ISO states this “serves a protective purpose” due to its
stimulatory effect on respiration (ISO/TS 16976-3: 2011). It not only increases
(via increased respiration) but also increases cerebral blood flow (due to vasodilation
or widening of blood vessels in the brain) (ISO/TS 16976-3: 2011).
However, there are adverse affects of CO2 re-breathing which cause problems
for the wearers of RPDs.

Silverthorn (2004) describes CO 2 as a “toxic waste

product” that must be removed from the lungs. The build up of which can produce
symptoms of discomfort, fatigue, dizziness, headache, shortness of breath, muscular
weakness, ringing in the ears, drowsiness, paralysis of the respiratory centre and even
asphyxiation or death depending on length of exposure (Kloos and Lamonica 1966).

8

Early evidence that high PaCO2 had negative effects was reported by Parker, Peters
and Barnett (1963).

They found, working on dogs, high PaCO2 decreased

compliance and increased work of breathing (Parker, Peters, and Barnett 1963).
In addition, several studies (Love et al. 1979, Takahashi et al. 2000 and
Fletcher, Clarke and Stanley 2006) showed that breathing CO 2 resulted in increases
in VE. The National Institute for Occupational Safety and Health (NIOSH) (1976)
reviewed 19 studies on CO2 re-breathing and concluded that excess V E can occur as
low as 1.1% inhaled CO2. Even still, a study by the National Aeronautics and Space
Administration (NASA) in 1971 (also cited in NIOSH 1976) showed that inspired
CO2 of 7.5 mmHg (0.99%) increased ventilation by 19%. Some outcomes have also
linked high PaCO2 with decreased exercise capacity (Bishop et al. 1999). Similarly,
research by NASA (1971) (cited in NIOSH 1976) showed a significant reduction in
maximal oxygen uptake (

) (down 13%) when inhaled gas contained 15

mmHg PCO2 (2% CO2).

is used as a standard measure of cardiorespiratory

fitness in exercise physiology.
Increased PaCO2 can have multiple effects on the central nervous system.
Yang, Sun and Sun (1997) demonstrated that 2.5% CO 2 in breathing air decreased
participants ability to detect motion.

Fothergill, Hedges and Morrison (1991)

established that moderate 6.18 kPa to high 7.5 kPa (6.2-7.5%) levels of CO2 impaired
cognitive and psychomotor performance. Luksch et al. (2002) also found breathing
CO2 ranging from 2.5-8% decreased retinal blood flow (cited in ISO/TS 16976-3:
2011). It can be assumed such effects are more likely to increase cognitive errors
and ability to perform tasks in the workplace.
In terms of determining an upper limit for PaCO2, Maresh et al. (1997)
showed that inhalation of 6-8% CO2 caused an increase in

(up 73%) and body

sensations of dyspnoea, heart palpitations, sweating, dizziness, pressure in chest or
blurred vision. There is also a condition known as extreme hypercarbia (supercarbia)
where a blood level of 19.9 kPa (150 mmHg or 19.9% CO2) occurs in individuals
with respiratory disease (ISO/TS 16976-3: 2011). Lastly, a study by McArdle (1959)
exposed individuals to 30% CO2. This experiment resulted in ECG abnormalities,
marked increase in blood pressure (BP) of 205/110 mmHg and unconsciousness.
Essentially to test this level of CO2 exposure would be unethical in present day
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research. However, from these studies it is evident that a wide range of acute CO2
conditions can be tolerated. Table 2.1 is a summary of these cited effects.

Table 2.1 Cited acute physiological effects of carbon dioxide re-breathing on
humans
PICO2
Physiological Effects
Reference
(%)
NASA (1971)
1
↑ by 19%
↑ VE
NIOSH
1.1
(1976)
NASA (1971)
2
↓
↓ ability to detect coherent motion
Yang et al.
2.5
(1997)
Decreased retinal blood flow
Luksch et al.
2.5-8
(2002)
↑ VE & PECO2
Craig et al.
3
(1970)
Breathlessness and Headache
Love et al.
4-5
(1979)
Maresh
et al.
6-8
↑ , dyspnoea, heart palpitations, sweating, pressure in
(1997)
chest, wobbly legs, dizziness and blurred vision
↑BP,
ECG
abnormalities
and
unconsciousness
McArdle,
30
(1959)

The health effects of long-term elevated CO2 in the atmosphere have been reported
on to a lesser extent. Yet, this is an important factor to consider, especially for
workers who are exposed to elevated CO2 on a daily basis. Many studies show that
participants become adapted to CO2 following chronic exposure.

For example,

submariners exposed to high CO2 over a period of 11 days in a study by Margel,
White and Pillar (2003) showed reduced respiratory disturbance during the collection
of sleep and breathing data. However, there is evidence to suggest that long-term
high CO2 exposure does have serious health implications. Drummer et al. (1998)
exposed participants to 1.2% CO2 in a deep diving chamber for 25 days. Follow up
measures showed elevated concentrations of serum calcium and slightly lower
biomarkers of bone formation and increased bone re-absorption in participants.
Further research regarding the impact of long-term exposures to CO2 is needed.
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2.2.2 Carbon dioxide re-breathing in respiratory protective devices
Physiological responses to CO2 are well documented. Yet, there is little scientific
literature available regarding CO2 re-breathing in RPDs. This present study aimed to
assess the impact of CO2 re-breathing in a full face non-powered air purifying RPD.
From the research examined it was evident that even less information was available
on this topic. Refer to a detailed summary of studies on CO2 re-breathing in different
types of RPDs and the variables that were measured in Table 5.1 (Appendix A).
These studies have produced mixed results.
Love et al. (1979) studied respiratory responses to inhaled CO2 under work
conditions using a device that had similar breathing resistances to a standard filter
self rescuer. Self rescuers are emergency RPDs often used for protection against
carbon monoxide, it is not self contained or oxygen supplying. The study found that
the symptoms of breathlessness and headache occurred at 4% and 5% PICO2. Love
et al. (1979) concluded that CO2 was not well tolerated at concentrations above 3% in
RPDs. Similarly Craig et al. (1970) studied CO2 re-breathing in M9 Protective
Masks and found that concentrations of 3% PICO2 or above produced a significant
reduction in endurance. A recent study by Takahashi et al. (2000) showed that
participants breathing 3% CO2 from a half mask had higher VE and percentage of
expired CO2 (PECO2) than participants breathing room air and that these responses
were augmented during moderate exercise. Consequently Takahashi et al. (2000)
recommended a minimum level of 2% CO2 as a safer limit with present day RPDs.
From these findings it is clear that increased PCO2 causes dyspnoea in RPDs.
However, these studies have a number of limitations including that CO2 was
administered to the participants. Further research is required to demonstrate the level
of CO2 re-breathing that occurs in the dead space of a RPD due to the incomplete
removal of exhaled air.
Arad et al. (1992) found that increased PICO2 was linked with increases in
in powered air-purifying respirators (PAPRs). A total of 10 participants (five
women) were involved in two exercise sessions wearing a full face RPD with and
without a blower. Each session involved six minutes at rest and six minutes of
walking on a treadmill at 5.1 km hr (3.2 miles hr) and 10% incline. Results indicated
that the blower significantly decreased PICO2 (0.4±0.4% and 1.3±0.7%) There was
some evidence that these changes were associated with improved RPD comfort.
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Arad et al. (1992) study also revealed female participants showed significantly lower
PECO2.
Roberge et al. (2010) examined the physiological impact of N95 filtering face
piece RPDs.

Ten adults (seven women) conducted two 60 minute treadmill

assessments walking at 2.74 km hr (1.7 miles hr) and 4.02 km hr (2.5 miles hr) while
wearing the RPD. Data collected showed that the RPD did not have a significant
physiological impact on the wearer. However, the dead space CO2 levels ranged
from 2.5-3.5% which is significantly above design standards (1%). This suggests
that CO2 re-breathing has the potential to occur in RPDs. The results indicated that
only modest elevations in transcutaneous CO2 (PcutCO2), equivalent to PaCO2,
occurred. However, two participants did have P cutCO2 equal to or greater than 50
mmHg (6.7%). In addition only mixed inhaled and exhaled CO2 was measured
rather than measured separately.

This could overestimate the level of CO 2 re-

breathing. Further research using a more representative sample and measurement of
inspired CO2 only is needed.
In contrast, other studies on RPDs have examined the physiological impact of
dead space which is well known for contributing to CO2 re-breathing. A study by
Johnson et al. (2000) showed for each 350 mL of external dead space imposed on the
participants a 19% decrease in performance time and an 18% decrease in breathing
comfort occurred. Warkander and Lundgren (1995) conducted a study on the impact
of dead space in three diving RPDs. Experiments were performed on a bicycle
ergonometer at three different workloads. Warkander and Lundgren (1995) found
that dead space was not constant in RPDs and increased with increased ventilation
during exercise. High PICO2 levels also occurred during periods other than rest.
The effect of breathing resistance in RPDs is also viewed as a key factor in
CO2 re-breathing. Harber et al. (1982) showed dead space (CO2 re-breathing) had
“effects similar to those of exercise”, this includes increased V E and
resistance led to hypoventilation.

, yet breathing

Furthermore, studies by Johnson, Dooly and

Dotson (1995) and Warkander et al. (1992) demonstrated that increased PCO2 in
RPDs was largely associated with breathing resistance. According to ISO the normal
response of increased respiration due to CO2 re-breathing is blunted when in the
presence of breathing resistance (ISO/TS 16976-3: 2011). Resistance is a problem in
most RPDs as the wearer has to overcome the filter resistance when breathing (the
12

majority of RPDs have some sort of filter to capture particles or gas). Breathing
through RPD resistance stimulates a “negative cycle” of hypoventilation, which can
cause increased CO2 partial pressure (Craig et al. 1970, Johnson et al. 2005 and
ISO/TS 16976-3: 2011). This stimulates respiration and potentially even further CO2
re-breathing. This will increase the level of hypercapnia to the point that it can cause
physiological stress or dyspnoea for the wearer. In turn this will result in decreased
wear time of the RPD.
From the research examined it is evident that multiple factors contribute to
increases in PCO2 in RPDs. Louhevaara et al. (1985) results suggest that symptoms
of hypercapnia (increased V E) may be influenced by the interaction of dead space
(volume of the RPD), breathing resistance as well as the weight and psychological
stress of the RPD. Suzuki, Ogawa and Matsumura (2004) put forward that factors
such as filtering face pieces that contained carbon, replaceable particulate RPDs and
gas masks without an inhalation valve or gas masks with inhalation valves with “lack
of air tightness” may also give rise to CO2 re-breathing. Sinkule and Turner (2004)
also found that the degree of PCO2 varied considerably between devices, body
weight and gender (2004). More research into CO2 re-breathing in RPDs is required
to evaluate these factors.

2.3

Occupational Exposure Standards

The adverse effects of CO2 have been known for some considerable time. As a result
there are several occupational exposure standards that specify the maximum
allowable concentrations of CO2. Safe Work Australia (SWA) specify a exposure
limit for CO2 of 0.5% (5, 000 ppm) over an eight hour time weighted average (SWA
2012). Similarly, OSHA has also set the same limit (OSHA 2011). NIOSH (2011)
state a maximum concentration of 0.5% (5, 000 ppm) for the workplace (40 hr
week). In respect to short term exposure limits for CO 2, SWA (2012) stipulates 3%
(30, 000 ppm) for 15 minutes as a limit. NIOSH (2011) also consider a CO2 value of
4% (40, 000 ppm) to be immediately dangerous to life or health.

13

In regards to specifications for maximum concentrations of inhaled CO 2 in the design
of RPDs, standards generally vary between 1% and 3% in different countries
(summarised in Table 2.2). In Australia the main organisation that governs these
standards is Standards Australia.

The Australia/New Zealand Standard: 1716

(AS/NZS 1716: 2003) “Respiratory Protective Devices” states CO 2 concentration of
inhaled air (including dead space) in full face pieces and head coverings (excluding
self rescuers and smoke masks) must not exceed a 1% average. This specification is
also applied in the Occupational Safety and Health Standards of OSHA: 1910.134
“Respiratory Protection” and European Standards: EN 13274-6: 2001 for respirator
classification.

The Israel Defence Force (IDF) regulations state the fraction of

inspired CO2 should not exceed 2% for longer than one consecutive minute in RPDs
(as cited in Luria et al. 2004).

Japan International Standards (JIS) however,

recommends a maximum of 3% (Takahashi et al. 2000). In regards to the mentioned
IDF and JIS standards English versions of these documents could not be accessed at
the time of the literature review.

Table 2.2 Summary of maximum allowable concentration of carbon dioxide in
inspired air in respiratory protective devices
Standard Maximum Allowable Concentration
RPD Type
(%)
AS/NZS
1.0
Full face pieces and head
coverings
AS/NZS
1.5
SCBA
AS/NZS
2.0
Smoke masks
EN
1.0
Independent air supply

Interestingly many of these current standards, such as AS/NZS 1716: 2003 and EN
13274-6: 2001 test for PCO2 using a “Sheffield” dummy head attached to a breathing
simulator. In AS/NZS 1716: 2003 the

of the machine is fixed to 20 breaths per

minute with a tidal volume of 2.0 L. A 5% CO2 air mixture is exhaled into the face
piece and inhaled CO2 is analysed.

It is therefore, important to research the

respiratory responses to CO2 during exercise (greater than 20 breaths per minute).
Furthermore it is essential to evaluate CO2 re-breathing in a human wearer.
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2.4

The Physiological Impact of Respiratory Protective Devices

There is a vast range of RPDs available. According to NIOSH (2011) RPDs belong
in two main categories:
1. Air purifying: These filter air before it is inhaled by the wearer and can
be disposable or non-disposable.


Particulate RPDs



Vapour and gas removing cartridges and canisters



Non-powered air-purifying respirators



Powered air-purifying respirators (PAPRs)

2. Air supplying: These RPDs independently supply air to the wearer.


Self contained breathing apparatus (SCBA)



Closed circuit



Open circuit



Supplied-air RPDs



Airline RPDs



Hose masks

Within this, there are numerous types of filters which include particulate (filter out
particles), vapour and gas removing masks and filter effectiveness (e.g. 95%, 99%
and 100%) (NIOSH 2011). After reviewing 15 studies on CO2 re-breathing (refer to
Appendix A) less than half focused on non-powered air purifying RPDs, three used
SCBAs, two used full face masks used in diving and two were on PAPRs. The
remaining studies used apparatuses to simulate RPDs.
Many studies reported a range of PCO2 levels and physiological responses to
RPDs (for example Harber et al. 1991, Luria et al. 2004 and Sinkule and Turner
2004). Harber et al. (1991) studied the effect of three alternative RPD designs and
found that powered air-purifying RPDs had less physiologic impact than the nonpowered models. However, they found no differences between RPDs with and
15

without a nasal deflector in place (a device that directs air flow in RPDs). Similarly,
Luria et al. (2004) found that despite using two very similar RPDs during rest and
exercise, very different levels of CO2 accumulation and work of breathing was
observed.
Given the above evidence, it is not surprising to assume each type of RPD
will exert different physical effects on the wearer. Table 2.3 below is modified from
Szeinuk et al. (2000) and provides a summary of some of these physiological-based
stressors.
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Table 2.3 Summary of the physiological effects of respiratory protective devices by Szeinuk et al. 2000
RPD
Respiratory
CardioDiscomfort
Ergonomics
Psychosocial
vascular
Air-Purifying
Little breathing
Few
Thermal load;
Few
Yes
(Negative
resistance; difficulty in
Tightness; Pain
Pressure)
cough; full-face mask;
increased dead space
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Powered Air
Purifying
(Continuous
Flow)

Little breathing
resistance; cough
difficulty

Few; some
models
add load

Airline;
Compressor or
Tanks

Cough difficulty;
demand regulator
(negative pressure) may
increase breathing
resistance; full face
mask increase dead
space
Cough difficulty; Full
face mask increases
dead space

Few

SCBA

Yes;
heavy load

Skin

Senses

Yes

Speech communication
difficult; smell
interference; full face
mask may interfere
with vision
Speech communication
difficult; smell
interference; full face
mask may interfere
with vision
Speech communication
difficult; smell
interference; full face
mask may interfere
with vision

Thermal load
(less than
negative
pressure);
tightness; pain
Thermal load
(less than
negative
pressure);
tightness; pain

Few; Some
models add
load to face and
belt

Yes

Yes (for
tight
fitting)

Air hose may
be heavy and
cumbersome

Yes

Yes (for
tight
fitting)

Thermal load
(less than
negative
pressure);
tightness; pain

Unit add weight
and volume to
user

Yes

Yes (for
tight
fitting)

Speech communication
difficult; smell
interference; full face
mask may interfere
with vision

From Table 2.3, the most important of these differences is the level of breathing
resistance and dead space of the RPD. Any breathing resistance at all will impede
breathing (Johnson et al. 2000) and thereby increase PaCO2.

In a similar way

increased dead space will result in CO2 re-breathing and hence elevated PaCO2. It is
these differences that may contribute to the mixed results observed in the literature
review.
Where dead space varies between RPDs, breathing resistance is standardised.
According to AS/NZS 1716: 2003, exhalation for air filtering RPDs is 200 Pa for full
face pieces and 120 Pa for half face pieces. In regards to inhalation resistance this
varies with the filter efficiency. Table 2.4 is extracted from AS/NZS 1716 standard
4.3.4 and defines the levels of maximum inhalation resistances that can be imposed
by an RPD (except PAPRs).

These levels can be measured using a pressure

transducer.

Table 2.4 Inhalation resistance in respiratory protective devices (AS/NZS 1716)
Filter class
Filter assembly only maximum
Assembled RPD maximum
resistance (Pa)
resistance (Pa)
30 ± 1 L min-1
95 ± 1 L min-1
30 ± 1 L min-1
95 ± 1 L min-1
P1
60
210
110
340
P2
70
240
120
370
P3
120
420
170
570

For this research a full face non powered air purifying RPD was used with a
Sundstrom SR P510-310 P3 particulate filter (see Figure 2.2). Hence by only using
one RPD model the variability associated with dead space and breathing resistance
will be minimised.
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Figure 2.2 The full face non powered air purifying respirator

2.5

Evaluation of Research Methods

The assessment of CO2 re-breathing in RPDs is quite complex. Firstly, the RPD
needs to be altered for the collection and analysis of inspired and expired gases. In
addition, the methods and equipment used to test RPDs all vary.

Table 5.1

(Appendix A) attempts to document studies on CO2 re-breathing. The following
sections considers the different research methods and equipment used to study CO2
re-breathing in RPDs.

2.5.1 Analysis of arterial carbon dioxide
One method to assess PCO2 in RPDs is to measure the accumulation of CO2 in the
individual’s blood. In the past a standard technique to do this was by obtaining
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arterial blood samples (PaCO2). However, in recent times the indirect analysis of
PECO2 or end tidal CO2 (PETCO2) gas samples has replaced this method, especially
in laboratory settings (ACSM 2006). PETCO2 is the final and highest CO2 reading
recorded at the end of exhalation (John 2003). In discussing P ETCO2 John (2003)
noted that this method was: “a non-invasive estimate of alveolar ventilation status by
its close correlation with PaCO2”. Hence a benefit of analysing respiratory gases
includes that arterial blood does not need to be drawn from the participant regularly,
such as every minute (Wanger 1996).
Transcutaneous CO2 monitoring is another practice that is non-invasive in
blood CO2 analysis. Electrodes are placed on the surface of the skin, such as the
forearm, chest, abdomen or earlobe and indirectly measures PaCO2. This was used
in the study by Roberge et al. (2010). These findings suggest analysis of CO2 via
non invasive methods is an acceptable method for the study of CO 2 exposure in
RPDs. These methods are preferred for this research as it is a field based study.

2.5.2 Measurement of inhaled carbon dioxide
As expired CO2 may not completely leave the RPD the level of CO2 inhaled is a key
parameter in this research.

A study by Mojoli et al. (2008) found that the

concentration of CO2 re-breathed was dependent on the level of PECO2. Mojoli et al.
(2008) conducted a series of tests to assess the most convenient method to monitor
PICO2 by sampling CO2 at different sites within a helmet. Their results showed that
PICO2 is best measured at either a “quiet” point inside the device or at the airway
opening. Mojoli et al. (2008) observed that CO2 concentration was not static within
the helmet, for example measurement of end PICO2 at the airway opening grossly
underestimated PICO2.
Similarly, ISO/TS 16976-3: 2011 noted that CO2 in the breathing zone of
RPDs varies. At the end of exhalation (PETCO2) can be as high as 8%, yet this
concentration will decrease rapidly at the start of the following inhalation to
approximately 1%, especially in a device with small dead space (ISO/TS 16976-3:
2011). Due to this variability separate collection and analysis of the level of CO2 in
both inspired and expired air in RPDs is necessary. According to the European
Standard, EN 13274-6: 2001 on determination of CO2 inhalation in RPDs a CO2
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sample probe should be placed at a point 50 mm in front of the device inlet. Hence
measurement of PICO2 should occur as close to the breathing port as possible. John
(2003) also supported this sampling technique.

2.5.3 Carbon dioxide gas analysis
There are several types of analysers (chemical sensors) used for the measurement of
CO2 (refer to Appendix A for a table of equipment used in past research). This
includes gas chromatographs, infrared absorption analysis or mass spectrometers.
According to Wagner (1996) gas chromatography was a technique used more in the
past. This involves a sample of expired air being collected and analysed for CO 2.
However, this process is quite expensive and requires several technicians.
The infrared analyser has been the preferred analyser for quite some time in
CO2 analysis (Wagner 1996). Louhevaara et al. (1984), Mador et al. (1992), Sidney
and Poon (1995), Luria et al. (2004) and Fletcher, Clarke and Stanley (2006) all
measured inspired CO2 using infrared analysers. This is a less accurate method
compared to mass spectrometry, however, preferred as it is less expensive and allows
analysis of many participants (Wagner 1996).
From the research examined mass spectrometers were used less frequently in
CO2 analysis despite reported rapid response and increased accuracy. According to
Wagner (1996) mass spectrometers are limited by its relatively large size and are the
most expensive to use.

Some studies that measure CO 2 in RPDs with mass

spectrometers include Mador et al. (1992), Stromberg and Eklund (1996) and Caretti
et al. (2001).
In relation to CO2 collection, there are also two main approaches. There is
the breath by breath method which measures data continually during each breath.
According to Wagner (1996) and Goodman and Curnow (1995) this method is quite
fast which allows for more data points to be collected. Secondly, there is the mixing
chamber method which uses a small compartment to collect gas samples, where CO2
is later analysed downstream. Wagner (1996) states this method does not require
high speed analysers or adjustment for time delays as in the breath by breath method.
However, it is limited by the fact that samples, such as expired air or air in the
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mixing chamber cannot be analysed at the same time. Despite this the results of the
literature review show that both these methods are acceptable in RPD research.

2.5.4 Measurement of dead space
One of the main issues that cause CO2 re-breathing is the volume of dead space.
Dead space refers to the portion of each breath that does not take part in gas
exchange (Brooks, Fahey and Baldwin 2005). According to McArdle, Katch and
Katch (2001) dead space in humans (anatomical) ranges between 150-200 mL or is
equal to 30% of resting VT. With a RPD, the dead space involved in respiration
increases, which can lead to the build up of CO2 as there is more potential for expired
air to be re-inhaled. As a result, some studies focused on the physiological impact of
dead space when evaluating CO2 re-breathing in RPDs. Stromberg and Eklund
(1996) calculated dead space by using indirect measurements of inspiratory volumes
using a calibrated inductive plethysmograph and measurements of PCO2 with a mass
spectrometer.

However, this method had an error rate almost equal to 20%

(Stromberg and Eklund 1996).
Alternatively the study by Warkander and Lundgren (1995) measured dead
space of the device by filling it with water and measuring volume. This research
shows the measurement of dead space in the assessment of CO 2 re-breathing in RPDs
is an important aspect that could be included in this research.

2.5.5 Measurement of respiratory parameters
The measurement of respiratory parameters is standard practice in this research area.
Common respiratory variables such as

, VT, minute volume (VE) and lung function

variables such as forced vital capacity (FVC) and total lung capacity (TLC) was
included in some way in all the literature reviewed (refer to Appendix A).
There are two commonly used devices for the analysis of respiratory
parameters,

these

are

pneumotachometers

and

plethsymographs.

A

pneumotachometer is a device that measures air flow directly from the mouth. Of
the 15 studies that looked at CO2 re-breathing in RPDs more than half used a form of
pneumotachography

(refer

to

Appendix

A).

The

advantage

to

using

pneumotachometers is that they are considered to be more precise (Harber et al.
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1991). However, as this is measured at the mouth, the RPD is often modified to
allow the collection of expired air. This change alone could decrease the accuracy of
the results.
Alternatively, Harber et al. (1991), Butcher et al. (2006) and Bansal et al.
(2009) used plesthmography. This method involves placing elastic bands around the
participants trunk. During respiration the changes in the diameter of the chest wall
generates electrical signals that can provide data on respiratory volumes and flow
rates. The benefit of this method is that these calculations can be made without the
need to sample air flow at the mouth.
Berndtsson (2003) also published a paper on a new technique for measuring
PIAF. PIAF can be three to ten times higher than VE and refers to the maximal speed
achieved during a full inspiration (AS/NZS 1715: 2009). There has been research
that has suggested that analysis of PIAF may be a more important factor when testing
respiratory responses in RPDs (including Silverman et al. 1943 and Berndtsson
2004). In addition the flow meter used to measure PIAF is light weight, accurate,
does not add to the inhalation resistance of the RPD or have any problems with lag
(Berndtsson 2003). The flow meter is preferable for this research as it does not
impact on breathing resistance or increase dead space significantly, which could
increase PCO2.

2.5.6 Measurement of work of breathing
Stimulation of respiration due to CO2 re-breathing will result in increased work of
breathing (WOB). According to Butcher et al. (2006) the potential consequences of
increased WOB is reduced cardiac output, peripheral muscle fatigue and diminished
exercise capacity. Assessing only respiratory variables in this research may fail to
show significant increases in WOB. For example, Lofaso et al. (1995) evaluated
CO2 re-breathing in BiPAP devices and found a 1.3% increase in VE but nearly two
fold increase in the WOB (J L).
The measurement of WOB is the product of oesophageal pressure change and
lung volume (WOB=P.VT) (Butcher et al. 2006).

To measure this directly an

oesophageal balloon is inserted and is impractical in some research settings.
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Alternatively WOB can be calculated by using pressure and flow recordings
(Shykoff and Warkander 2011)
Increased WOB will also result in higher values of O2.

O2 is an indirect

measure of calculating the demands of energy expenditure (ACSM 2006).

By

definition O2 is the volume of oxygen used by the body to produce energy (ACSM
2006). Therefore, O2 can indirectly represent WOB. The calculation of O2 is a
much less invasive and straightforward approach to measure the demands of work.
There are a number of ways to accurately calculate O2. One method for calculating
O2 is to use ACSM (2006) metabolic calculations. For instance the leg cycling
equation for O2 is as follows:
(mL kg-1 min-1) =

1. (work rate)
body mass

+ 3.5 mL kg-1 min-1 + 3.5 mL kg-1 min-1

For the context of this research the above equation was the preferred method to
represent WOB.

2.6

Variables that Influence Carbon Dioxide Re-breathing

There are a number of factors that influence the assessment of PCO2 in RPDs. These
are important considerations when conducting research on RPDs. Some of these
issues will be mentioned in the section below.

2.6.1 Facial fit
RPD fit testing is an important procedure to ensure that a good face seal is achieved
and that the device protects the wearer from inhaling hazardous substances. For this
research RPD fit is important to ensure leakage factors do not limit results.
According to AS/NZS 1715: 2009 fit testing procedures include either a qualitative
or quantitative fit test. Qualitative fit testing generally involves the wearer detecting
the presence of a chemical agent either by taste or smell within the RPD.
Quantitative tests involve precise measurement of the amount of leakage that occurs
in an RPD by a contaminant. Measurement of leakage is undertaken using an
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instrument such as a “Portacount” which is considered to be one of the fastest and
easiest ways to do this. In addition this device is approved by OSHA (OSHA 2011).
In regards to fit testing both qualitative and quantitative fit tests are acceptable
(AS/NZS 1716: 2003).

Some studies have mentioned checking for face fit to

eliminate leaks before carrying out research (Jones 1991, Caretti et al. 2001, Rebar et
al. 2004 and Johnson et al. 2005).

2.6.2 Human variability
There are many variables that will affect participants level of CO2 re-breathing and
response to CO2. For example, participants sensitivity to CO2 can vary greatly. A
study by Takahashi et al. (2000) showed that the respiratory response ( , VE) of the
most sensitive person to CO2 was 10 times as high as that of the least sensitive
person. This may account for the Warkander et al. (1992) results which showed that
high levels of PETCO2 did not cause dyspnoea in some participants. In addition it has
been noted repeated exposure to CO2 will reduce an individual’s sensitivity
(Silverman et al. 1951).
Exercise has also been shown to impact PICO2.
moderate exercise respiration is proportional to

Firstly, during light and

and PECO2 (McArdle, Katch

and Katch 2001). At these intensities it can be expected to see increases in CO2 rebreathing with increased work. Warkander et al. (1995) showed a mean increase of
0.3 kPa (0.3%) CO2 when participants workload was increased from 50 W to 100 W
on a bicycle ergonometer. Secondly, two participants working at the same

will

have different levels of PECO2 and respiration (Kyriazi 2011). These differences
may be related to differences in body size, gender and fitness.
It is these reasons that Body and Metabolic Simulator (BMS) machines are
often used to test RPDs as there is better repeatability (Kyriazi 2011).

BMS

machines simulate mechanical breathing and metabolism of humans. However, it is
important to realise these machines are not without limitation. A study by Kyriazi
(2011) tested two different BMSs against each other and found notable differences in
PICO2.
To control for human variability, the aim of this research is to recruit a large
sample size to explore these issues further. It is worth noting that of the literature
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reviewed few studies had a sample size large enough to determine if for example
gender or body size had an influence on CO2 re-breathing in RPDs.

2.6.3 The impact of speech
Speech production, sometimes called phonic respiration is a particular act that affects
the dynamics of breathing even though it has nothing to do with gas exchange
(Boron and Boulpaep 2003, p733). The process of breathing provides air flows and
pressures that interact with the respiratory tract to create speech. Speech occurs
primarily during exhalation and as a result decreases inhalation time (ISO/TS 169761: 2007).
According to Boron and Boulpaep (2003) when persons read aloud,

can

increase by 25% and PACO2 falls. During heavy work the demand for alveolar
ventilation increases and as a result the ability to speak becomes increasingly
difficult.
It appears speech under conditions of high ventilatory demands (such as
exercise) has been well researched. For example, studies by Doust and Patrick
(1981) and Barker et al. (2008), found that VE and

is significantly lower during

simultaneous speaking and exercise tasks compared to non speech exercise tasks. It
is thought that this decrease in respiration is due to competition between the
breathing patterns required for speech and the breathing patterns typically used for
exercise. In addition both studies noted that

did not significantly differ between

the speech and non speech tasks.
Doust and Patrick (1981) also noted respiration overshot by 14% immediately
after the speech period. It was proposed that hypercapnia could explain the above
increase in respiration observed at the end of speech.
Research by Raczek and Asamczyk (2004) evaluated changes in speaking
fluency and the concentration of expired CO2. This study found that stutterer’s
whose speech is impaired, is linked to increases in CO2 concentration in exhaled air.
Therefore, there is reason to believe that speech may cause changes to the
concentration of CO2 in the breathing atmosphere of a RPD, particularly if speech is
obstructed (such as breathing resistance or increased work rate).
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In addition, a study by Hoit and Lansing (2007) looked into speech related dyspnoea
while breathing high levels of CO2.

Results showed that speech breathing

behaviours changed with inspired CO2. This included increased PETCO2, increased
lung volume expended per syllable and more non speech exhalations.
There is considerable research on the impact of RPDs and speech
intelligibility. All RPDs impact on communication by attenuation or distortion of
sound by some degree. Studies, for example by Caretti and Strickler (2003) have
revealed that interference with communications is regarded as one of the most
important factors limiting RPD compliance (Caretti and Strickler 2003).
Other studies have measured the effects of speech in RPDs under work
conditions including Silverman et al. (1943) and Berndtsson (2004).

Results

indicated breathing during speech was altered and led to significant increases in
PIAF. However, the impact of speech on CO2 levels in RPDs has not previously
been evaluated to our knowledge. Hence further studies measuring CO2 re-breathing
during speech in RPDs seems worthwhile.

2.7

Summary

Following a review of the literature it is possible to conclude that CO2 re-breathing is
a problem regarding the wear of RPDs. Dead space has long been regarded as a
primary cause for CO2 re-breathing in RPDs.

However, breathing resistance, a

common difficulty in all RPDs also contributes to this. Other factors that appear to
influence CO2 re-breathing in RPDs include increased CO2 production, for example
during exercise, BSA, gender and individual sensitivity to CO2.
A lack of published papers suggests that CO2 re-breathing in RPDs is an
under researched topic. Of 15 studies that measured PCO2 in RPDs few measured
PIAF, WOB, or changes to cognitive function.

In addition no studies have

specifically focused on the effects of speech on PCO2. Many studies on CO2 rebreathing were limited by small sample size, consequently the effects of body size
and gender appear unclear. It is apparent the level of CO2 re-breathing that occurs in
RPDs and its impact on human wearers could be better understood.
27

Therefore, with these factors in mind this research aims to measure the level of CO2
re-breathing that occurs in RPDs while performing work and to investigate its impact
on the wearer (for example dyspnoea). In addition, the impact of speech, gender and
BSA will be investigated using a more representative sample. This information will
assist manufacturers in improving the design of RPDs so that they are more suited to
the wearer’s respiratory responses. This potentially will lead to improving RPD
comfort and wear time.

28

3 METHODOLOGY

PILOT STUDY

A pilot study was conducted between February and March 2012 at the University of
Wollongong (UOW), New South Wales. The pilot study provided an opportunity to
test the assessment process with a group of volunteers before conducting the field
study. From this, methodological limitations were identified and overcome and
assessment procedures improved.
As a result of the information gained in the literature review it was
hypothesised that speech, BSA, gender and workload would influence CO2 rebreathing in RPDs. Also, it was apparent that CO2 re-breathing stimulates a range of
physiological and psychological effects including increased respiration and
dyspnoea. This may contribute to decreased RPD wear time and comfort.
The pilot study was approved by the Human Research Ethics Committee of the
UOW/South Eastern Sydney and Illawarra Area Health Service (Reference Number:
HE11/437 and Appendix B).

3.1

Participants

Participants were recruited for the pilot study from the School of Health Sciences at
the UOW. Participants were approached or recruited via verbal announcements and
email. Participation was voluntary and no incentives were offered. Participants were
informed of potential psychological and physiological discomforts of wearing a
RPD. A participant information sheet (PIS) further outlined the aim and potential
risks and benefits of the study (refer to Appendix C).
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Participants were required to be aged between 18 and 69 years, clean shaven and
pass a TSI Portacount fit test. The principle of this latter constraint was to ensure
that the RPD achieved an acceptable face seal on the wearer. Participants were
excluded if pregnant, suffering from severe illness or injury, diagnosed with severe
anxiety or problems with claustrophobia (refer to Appendix D for more information
regarding inclusion and exclusion criteria). In addition participants were required to
avoid exercise and smoking on the day of testing (refer to Appendix E for
appointment confirmation letter). If no contraindications to exercise were identified
using the screening materials detailed in section 3.1.3, participants were requested to
complete an informed written consent (refer to Appendix F).

3.2

Equipment and Instruments

The equipment used for the pilot study is illustrated schematically in Figure 3.1. The
apparatus was arranged with the following components:


S.E.A Full Face Mask (1)



A Validyne Pressure Transducer (2)



Data Acquisition Board (DAQ) (3)



Personal Computer (PC) (4)



Valve Controller (5)



O2/CO2 analyser (6)



Pump(s) (7 and 8)



Accumulator(s) (9 and 10).

The system was designed to collect separate volumes of exhaled and inhaled gas
concentrations by using three sampling probes located in the oronasal space of the
mask.

The apparatus developed was comparable to the preferred example for

determination of CO2 content in RPDs described in Australian/New Zealand
Standards (AS/NZS 1716: 2003). However, in this study a human wearer donned the
RPD rather than using a BMS machine to simulate respiration. The distinction here
is that where the BMS is set to exhale a 5% CO2 mixture, a human can exhale as
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much as 8% CO2 during exercise (ISO/TS 16976-3: 2011). A summary of the
equipment used is described below.

(1)
Mask

(2)
Pressure
transducer

V1

V2

(7)
Pump

(8)
Pump

(9)
Accumulator
(inhalation air)

(10)
Accumulator
(exhalation air)

V3

V4

(5)
Valve
controller
to ambient

V5

(6)
CO2 analyser

(3)
DAQ

(4)
PC

Figure 3.1 Schematic diagram of the test equipment by Crain and Kazakov 2011
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3.2.1 S.E.A Full Face Mask
A full face S.E.A Pty Ltd mask (SMF-L model, The S.E.A Group, Warriewood,
NSW) with a Sundstrom SR P510-310 P3 particle filter was selected. The RPD was
modified to allow for the analysis of respiratory parameters. This was done via three
independent probes located in the oronasal space of the RPD. One probe detected
flow and pressure, the remaining two sampling lines collected inhalation and
exhalation air samples via two valves (V1 and V2 in Figure 3.1). These valves
operated as one way valves and measured PICO2 and PECO2 separately downstream.
The participants breathed normal atmospheric air and were exposed to minimal
breathing resistance. The device was calibrated and validated by S.E.A Pty Ltd
using CE standards for RPDs. The full face RPD was worn as shown in Figure 3.2.

Figure 3.2 Participant seated on the bicycle ergonometer
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3.2.2 Flow measurement
A Validyne Differential Pressure Transducer (Model P55D, Validyne Engineering
Corporation, Northridge, California) (accuracy ±0.25b FS) was connected to the RPD

to measure PIAF. It was designed to measure a pressure drop in combination with a
standard Sundstrom SR 510-310 P3 particulate filter. The device was calibrated and
validated by S.E.A Pty Ltd prior to testing. The PIAFs published in this report was

modelled after Berndtsson (2004). PIAF was calculated as the mean of all breaths
during 30 seconds of each measurement period. The values were then corrected to
body temperature and pressure saturated with water vapour (BTPS).

3.2.3 Gas analyser
An O2/CO2 analyser (O2Cap, Oxigraph, Mountain View, US) single channel (5-100%
O2; 0-10% CO2 range) measured the concentration of PICO2 and PECO2.

The

analyser sampled air samples at a sample rate of 50 Hz, 250 mL min-1.

The

manufacturer listed ±0.1% stability for CO2. Gas samples were taken from two
separate probes located in the sampling port of the RPD and connected to the
analyser via two separate lines. The CO2 analyser was calibrated at regular intervals
using certified reference gases (0% CO2 and 5% CO2).

3.2.4 Personal computer
A Data Acquisition (DAQ) board was connected to personal computer (PC) to
perform O2 and CO2 management, valve control and collect pressure and flow
measurements. Data was stored in a S.E.A software program as CSV files. These
results were imported into a Microsoft Excel 97 (Microsoft Corporation) spreadsheet
for further analysis.

3.2.5 Bicycle ergonometer
The exercise test was performed on a calibrated bicycle ergonometer (Monark
Bodyguard AB, Varberg, Sweden) with Monarch analysis software. The seat height
was adjusted to the preference of the user, ideally so that their knee had a five degree
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bend when extended. Participants were instructed to maintain a pedal rate of 60
revolutions per minute (rpm). The Monark software was used to convert kilopond to
watts, to adjust workload automatically and record test data.

3.2.6 TSI Portacount
A calibrated TSI Portacount Plus (TSI Incorporated, Shoreview, MN, USA)
quantitatively calculated RPD fit. This instrument works by measuring the particle
concentration in an ambient air sample and comparing this to inside the mask to
provide an estimate of RPD fit (TSI 2011). The ratio of these two variables is called
a fit factor. For the full face mask an overall fit factor of greater than 500 is required.
The TSI Portacount was pre-programmed with eight one minute exercises contained
in the OSHA regulations (OSHA 2011). Participants were required to obtain a pass
for each exercise to be included in the study.
A HP Pavilion G series laptop with TSI software was in command of the TSI
Portacount during fit testing. Daily checks were performed on the TSI Portacount at
the start, middle and end of each day of testing to ensure it operating accurately. This
was done by following the instructions provided by the manufacturer. This equipment

and method was chosen to carry out the fit test as it is commonly conducted in many
workplaces.

3.2.7 Heart rate monitor
Participants HR was measured throughout the exercise test using a Polar HR monitor
(Polar FT1, Polar Electro, Kempele, Finland). The chest belts were moistened and
fixed around or just below nipple line of participants.

3.2.8 Modified Borg Scale
CO2 produces symptoms of shortness of breath and dyspnoea. A visual analogue
scale to gauge participant’s level of dyspnoea is therefore, a valid and useful tool for
this research. The Modified Borg Scale (MBS) is a visual analogue scale which
allows participants to communicate their level of breathlessness and can be accessed
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from the Australian Lung Foundation (2011). A well known study by Kendrick,
Smith and Baxi (2000) was able to demonstrate that this scale correlated well with
respiratory variables and can be used to measure dyspnoea.
The MBS allows participants to rate their level of breathlessness from 0
(Nothing at all) to 10 (Maximal). Scores 7 or greater (very severe) was considered
termination criteria for the assessment. Refer to Appendix H for more termination
criteria in regards to the exercise test.

3.3

Screening materials

Prior to testing the participants were requested to complete the Physical Activity
Readiness-Questionnaire (PAR-Q) (Appendix I).

This form consists of seven

questions that can detect medical contraindications to exercise. ACSM recommends
the use of this questionnaire as a safe pre-screening tool to identify adults who
should not participate in exercise (ACSM 2006). If participants answered no to all
PAR-Q questions they were permitted to take part in the exercise test.
A pre-screening questionnaire (Appendix J) was also designed to collect
participants demographic data, it asked for information such as age and gender as
well as smoking status, history of lung problems, issues with anxiety or
claustrophobia, physical activity levels and experience with RPDs. This was adapted
from the Occupation Safety and Health Administration (OSHA) Respirator Medical
Evaluation Questionnaire. According to OSHA (2011) this information is important
when evaluating an individual’s suitability for the use of RPDs.
Lastly, the State-Trait Anxiety Inventory (STAI) (Appendix K) was used to
measure participants symptoms of state and trait anxiety (Spielberger et al. 1983). In
a review of the literature it was apparent that RPDs can increase symptoms of
anxiety. Williams (2010) highlighted that individual’s diagnosed with anxiety or
problems with claustrophobia are more susceptible to the adverse effects of PCO 2.
The Speilberger State- Trait Anxiety Inventory (STAI) is a widely used assessment
tool to evaluate how anxiety can interfere with RPD use (Caretti et al. 2001, Johnson

35

et al. 2005 and Koh et al. 2006). Some studies have also used the STAI to exclude
participants who are prone to anxiety in RPD trials.
Therefore the STAI was used as an additional pre-screening tool for
participants at risk of test associated discomfort.

The first 20 items of this

questionnaire, S-Anxiety scale (STAI Form Y-1) measure how the respondent feels
“right now, at this moment”. Each item consisted of a direct statement (e.g. “I feel
calm”) and participants were instructed to rate the strength of their agreement on a
scale from 1 (not at all) to 4 (very much so). Scores for each item ranged between 1
and 4.
The last 20 items, the T-Anxiety Scale (STAI Form Y-2) in the questionnaire
measured how participants “generally feel”. Each item comprised of a statement
(e.g. “I feel pleasant”). Participants were instructed to rate their level of agreement
of each item on a scale from 1 (almost never) to 4 (almost always). Similarly each
item scores ranged between 1 and 4.
Final scores for each scale could range between 30 and 80. If participants
scored in the 90th percentile or above, this was indicative of severe anxiety and they
were excluded from the study. According to Szeink et al. (2000) a questionnaire to
identify a psychological condition, such as severe anxiety can be utilised to
determine whether an individual will be suitable to wear a RPD. The STAI was
chosen as it is a definitive instrument for measuring anxiety in adults and has also
been used effectively as a pre-screening tool in past RPD research (for example
Johnson et al. 2000).

3.4

Procedures

The testing for the pilot study took place in the Occupational Health and Safety
laboratory at UOW, New South Wales, Australia. The laboratory temperature and
relative humidity was recorded before testing. Participants were instructed to wear
comfortable sporting clothes and running shoes, be clean shaven, to not exercise on
the day of the appointment or consume any alcohol, caffeine, cigarettes or heavy
meals three hours prior to the appointment.
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3.4.1 Anthropometric measurements
Following completion of the questionnaires and pre-screening materials participants
initial anthropometric measurements (without shoes and heavy clothes) were taken.
The height of each participant was recorded with a stadiometer to the nearest 0.5 cm.
The weight of each participant was measured with a calibrated, electronic portable
scale to the nearest 0.5 kg. Participants BSA was calculated using the Dubios
formula highlighted in the ISO/TS 16976-1: 2007 specifications.

3.4.2 TSI Portacount fit test
In order to be included in the study the participants were required to pass a
Portacount fit test (refer to Figure 3.3). This procedure was important to ensure that
the RPD achieved a good face seal on the wearer and that no leakage factors limited
the results. A minimum fit factor pass level of 500 was necessary.
Participants were asked to put on a large RPD which was connected via an
adapter to the TSI Portacount. The participant was allowed enough time to feel
comfortable wearing the device and the fit around the eyes, nose and cheeks was
checked.
Participants were then asked to perform a series of eight exercises lasting one
minute each while wearing the RPD. During each exercise the TSI Portacount would
measure face seal leakage. The eight exercises consisted of normal breathing, deep
breathing, turning the head side to side, moving head up and down, talking (loud
reciting of a written passage), grimacing (smiling or frowning), bending over and
normal breathing.
The TSI Portacount was able to show in real time if the participant passed or
failed at the conclusion of the test. The result was coded and the participant was
prepared for the exercise test.
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Figure 3.3 Participant completing the respirator fit test

3.4.3 The exercise test protocol
In preparation for the exercise test participants resting HR and BP was obtained
while seated on the bicycle ergonometer. The seat height of the bicycle ergonometer
was adjusted and the procedures for the test described. To study the effects of
exercise on the outcome parameters a range of exercise intensities were selected (75
W, 100 W, 125 W, 150 W and 175 W). Appendix O depicts the exercise protocols
and record forms (low and high level).
The test began with a sufficient minute warm up at 50 W and a pedal rate of
60 rpm. The starting pedal resistance began at 75 W or 100 W depending on the
participant’s body size, gender or estimated fitness. The protocol consisted of 25 W
increments every five minutes or after a steady state HR was reached (two heart rates
within 5 beats min-1). Steady HR was deemed to be obtained when there was no
variation in HR of more than five beats per minute. Participants were encouraged
not to talk for the first three minutes. At the end of third minute they were asked to
read the from the rainbow passage for one minute (refer to Appendix L for the
Rainbow Passage).
During minute two (no speech) and minute three (speech) of each stage gas
analysis and measurement of the physiological parameters (HR, MBS, PIAF) was
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conducted. During the fourth minute participants were encouraged not to speak to
allow their breathing and HR to normalise.
Each assessment was approximately 8-22 minutes in length depending on the
participants fitness levels and signs or symptoms. All participants could voluntarily
halt the assessment process at any time. The test was terminated after four stages,
volitional fatigue or when the participant reached 85% of their predicted maximum
HR. Refer to Appendix H for further termination criteria.
At the end of the test, resistance was reduced to 50 W or lower and the
participant was allowed time to cool down for a minimum of two minutes. The
participants results were immediately coded and filed. When the test was stopped
the participant removed the RPD which was subsequently cleaned in preparation for
the next assessment. Participants were also asked to provide any feedback on any
test or RPD related discomfort experienced during the assessment. Participants were
thanked for their participation.

FIELD STUDY

The field study was conducted over one week between April 16 and 20, 2012 at a
worksite in Mount Isa, Queensland. The logistics, promotion, administration and
delivery of the field study will be described in the following sections. The goal of
the field study was to identify and understand the impact of CO 2 re-breathing in
workers who use RPDs as part of their employment duties. A large sample size was
a key goal of the field study and would provide a more detailed analysis of the
problem and its impact.
The field study was approved by the Human Research Ethics Committee
(HREC) of the UOW/South Eastern Sydney and Illawarra Area Health Service
(Reference Number: HE11/437 and Appendix B). A process map for the field study
is provided in Figure 3.4.
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Stage 1Logistics
Week of
March 5

Stage 2Promotion
Week of March
12-April 2

Stage 3Confirmation
Week of April
9

Stage 4Delivery
Week of
April 16-20

• Initial
meeting
with site
contact
• Confirm
assessmen
t dates,
location,
room
availability
& building
access.
• Arrange &
book
travel/
accomodati
on

• Send promotional
material (posters,
registration letter,
PIS & DVD).
• Site contact to
distribute posters
& leaflets to staff
• Site contact plays
promotional DVD
at the start/
conclusion of staff
toolbox meetings
• Site contact to
provide interested
participants with
registration letter

• Participants book
appointment. PI
Smith Populates
booking sheet.
• Participants
Included if
healthy,
experience with
RPDs, not
pregnant
• PI Smith mails/
emails
appointment
information
(consent form,
questionaires)
• PI Smith confirms
appointment time
. Review
bookings with
site contact

• Pack kit and
paperwork for
transport to Mt
Isa
• PI Smith arrive
at Mt Isa to
deliver
assessments
week of April
16
• PI Smith
complete
induction and
help to
promote
project
• Field study
complete and
analysis
conducted as
per
methodology

Figure 3.4 Process map for administration and delivery of the field study

3.5

Logistics

The population of interest for the field study was workers who used RPDs on a
regular basis. The first stage of the field study involved several logistical meetings to
make plans for the promotion and delivery of the research project at the worksite.
These meeting were between UOW research supervisors and the worksite site
program champions. The meeting involved discussions via telephone and email
regarding the research goals, explanation of the risks and benefits of being involved,
confirmation of the assessment dates and responding to any questions that the
worksite may have. PISs, consent forms, questionnaires and promotional materials
were forwarded to the worksite to assist with informing them of the assessment
process and procedures (refer to Appendix C to Appendix N).
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3.6

Promotion

Participants were recruited for the field study from a worksite in Mount Isa,
Queensland.

Dissemination about the research project to the workers was

undertaken using various strategies from word of mouth to the use of multi-media.
Participation was voluntary and no incentives were offered. Once the assessment
dates, location and times were confirmed the promotion phase began. The promotion
strategies used for the field study are described in section 3.6.1 to 3.6.3.

3.6.1 Posters and leaflets
Posters and leaflets were distributed to the worksite to display the assessment date,
time and location (Appendix M). Logistically this was an inexpensive way to
promote the research. In recognition of the HREC advice, the promotional materials
prompted that only the principal investigator (PI) or co-investigators (CIs) at UOW
were to be contacted by prospective participants to register their interest.

3.6.2 Promotional DVD and information sessions
In conjunction with the distribution of posters and leaflets a promotional 30 second
DVD was produced.

The DVD was designed so participants could be better

informed regarding the test procedures and who will be conducting the research. The
DVD was provided to the site contacts and workers as a more compelling and
personalised way than using posters and written formats to explain and encourage
participation.
The site contacts had the opportunity to play this DVD at staff meetings
leading up to the onsite assessments. Similarly, in recognition of the HREC advice,
the DVD encouraged that only PI Smith and CI Whitelaw were to be contacted in
regards to the research project. Refer to Appendix N for a copy of the recruitment
script.
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3.6.3 Mail out
A contact details form, PIS and self addressed envelope marked “Private and
Confidential” was circulated to the workers. Again, participants were instructed to
complete and return the form to PI Smith or CI Whitelaw in order to volunteer for
the project.

3.7

Confirmation

A total of 46 workers from a worksite in Mount Isa, Queensland were recruited for
the project. All volunteers were booked into an appointment during their normal
working hours. All participants received a PIS, pre-screening questionnaire and
appointment confirmation letter (refer to Appendix C, J, and E respectively).
Participants were required to be aged between 18 and 69 years, clean shaven
and pass a quantitative RPD fit test with a TSI Portacount.

Participants were

excluded if they had apparent health concerns or musculoskeletal injury (refer to
Appendix D for more information regarding inclusion and exclusion criteria). In
addition participants were required to avoid exercise and smoking cigarettes or cigars
on the day of testing (refer to Appendix E for appointment confirmation letter). If no
contraindications to exercise were identified following a complete health history,
resting HR and BP screening, participants provided their written informed consent to
participate (Appendix F).

3.8

Equipment and Procedures

The apparatus and procedures used in the field study were conducted under the same
protocols as those used in the pilot study which is described in section 3.2 – 3.4.3.
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3.9

Outcome Parameters

The key cardio-respiratory variables obtained were heart rate (HR), breathing
frequency ( ), peak inspiratory air flow (PIAF), dyspnoea (MBS), percentage of
inspired CO2 (PICO2) and percentage of expired CO2 (PECO2). Oxygen uptake
(

) was calculated using the metabolic equation for the total oxygen cost of

cycling (ACSM 2006). These parameters were measured against both conditions of
no speech and speech during each exercise stage.

3.10 Data Analysis

3.10.1 Data handling and management
Data was compiled into a Microsoft Excel 97 (Microsoft Corporation) spreadsheet
post assessment this included pre-screening instruments and the physiological
parameters measured.

The data was screened in this format for any potential

problems or errors. All analyses were completed using Statistical Package for the
Social Sciences (SPSS) version 19.

3.10.2 Statistical analysis
Descriptive statistics were used to report the physiological and demographic data
(age, weight, height and BSA) as mean and standard deviations.

To determine

whether there were any outliers the box-plot method was used for the six workloads.
Data points outside of the interquartile range (size of the box) were checked for
processing errors and subsequently remained in the data set for statistical analysis.
This was followed by inferential statistics using PICO 2 as the dependent variable.
The main test results were paired into speech and no speech and comparisons were
made across each of the six workloads (rest, 75 W, 100 W, 125 W, 150 W and 175
W). Independent variables included breathing condition (speech and no speech),
HR, gender, BSA,

, PIAF, PECO2 and MBS scores.
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To analyse the differences between the experimental conditions, speech and no
speech a paired t-test was used. Linear mixed models analysis was used to determine
whether significant differences existed in

and PICO2 across the six exercise

workloads. A significance level of p<0.05 (two tailed) was used for all statistical
analysis.
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4 RESULTS

PILOT STUDY

The aim of the pilot study was to assess the accuracy of the preliminary hypothesis.
In addition, it allowed for any methodological problems to be identified and resolved
in preparation for the field study. The results of the pilot study are provided in the
following sections.

4.1

Participants

A total of 22 participants (eight females) volunteered for the pilot study. Testing was
carried out in the Occupational Health and Safety laboratory at UOW, New South
Wales, Australia at an ambient temperature of 24°C, with an average relative
humidity of 60%.

The ages ranged from 18 to 58, with a mean age of 33

(SD=±12.4). The majority of these participants were non-smokers (n=20) and 59%
(n=13) reported that they were physically active or exercised on a regular basis.
State and trait anxiety scores were converted into percentile scores for a
normal adult population. The mean was 37% for state (participants anxiety at the
moment of testing) and 54% for trait (participants anxiety proneness).

No

participants were identified with severe or clinically severe levels of state and trait
anxiety which was additional exclusion criteria.
Of the 22 volunteers, all participants passed the medical clearance however,
23% (n=5) did not pass the TSI Portacount fit test. This data has been excluded from
the report unless otherwise specified. Refer to Table 4.1 for more demographic
information.
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Table 4.1 Demographic characteristics of the pilot participants
Participant

Gender

Age (years)

Weight (kg)

Height (m)

BSA (m2)

RPD Fit

1

M

27

75.0

1.74

1.89

PASS

2

M

26

75.0

1.81

1.95

PASS

3

F

32

49.0

1.71

1.56

FAIL

4

F

33

60.0

1.76

1.73

PASS

5

F

30

66.0

1.63

1.71

FAIL

6

M

39

85.0

1.85

2.08

PASS

7

M

35

87.5

1.79

2.06

PASS

8

M

56

78.5

1.78

1.96

PASS

9

F

53

63.0

1.53

1.60

PASS

10

M

58

78.0

1.73

1.91

PASS

11

F

56

78.5

1.68

1.88

FAIL

12

F

25

66.0

1.59

1.68

FAIL

13

F

26

70.0

1.69

1.80

PASS

14

M

29

68.2

1.85

1.90

FAIL

15

M

41

111.0

1.66

2.16

PASS

16

F

20

66.0

1.72

1.78

PASS

17

M

22

92.0

1.69

2.02

PASS

18

M

18

68.0

1.75

1.82

PASS

19

M

18

74.4

1.79

1.92

PASS

20

M

28

71.1

1.82

1.91

PASS

21

M

27

86.8

1.83

2.09

PASS

22

M

29

65.5

1.77

1.81

PASS

Mean

33.1

73.7

1.73

SD

12.4

12.9

0.08

M, Male; F, Female; BSA, Body Surface Area; SD, Standard Deviation

In regards to the exercise assessment, four participants did not reach 85% of their
maximal HR. Reasons participants requested to stop the exercise test before target
HR was reached included headache (n=1), development of lower back discomfort
(n=1) and general leg fatigue (n=2). Two participants speech fluency and quality
was reduced due to reported difficulty reading the prepared text during the exercise
assessment (participant 10 and 11). Post assessment all participants stated speech
increased symptoms of dyspnoea while wearing the RPD.
The duration that participants were able to complete the exercise assessment
varied from 8-21 minutes. PECO2 was higher than 7% in three participants which
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equates to a high PACO2 value (John 2003). One of these participants mentioned
feeling the onset of a headache and removed the RPD prematurely. Figure 4.1 is a
flow chart of the study cohort.

All participants
recruited for the
pilot study
(n=22)

Participants failed
Portacount fit test
(n=5)

Rest
(n=17)

75 Watts
(n=10)

Primary Analysis
(n=17)

100 Watts
(n = 17)

125 Watts
(n = 15)

150 Watts
(n=7)

175 Watts
(n=2)

Figure 4.1 Flowchart of the pilot study participants

4.2

Preliminary Results

The results of the pilot study are displayed in Table 4.2. The mean and standard
deviations (SD) for all the parameters measured at rest and different workloads can
be compared. The recorded outcome parameters included percentage of inspired
CO2 (PICO2), percentage of expired CO2 (PECO2), heart rate (HR), peak inspiratory
air flow (PIAF), dyspnoea (MBS) and oxygen uptake (

). The variables were

calculated across all six workloads (rest, 75 W, 100 W, 125 W, 150 W and 175 W)
and the two breathing conditions (speech and no speech).
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Table 4.2 Effects of speech on respiratory parameters during rest and exercise wearing a full face respiratory protective device
Rest

75 W

100 W

125 W

150 W

175 W

(n=17)

(n=10)

(n=17)

(n=15)

(n=7)

(n=2)

No Speech

PICO2

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

1.6

0.41

2.5

0.51

1.3

0.37

2.0

0.63

1.1

0.27

2.1

0.56

1.2

0.39

2.0

0.56

1.1

0.51

2.0

0.69

0.8

0.25

2.0

0.30

4.1

0.86

3.9

0.67

4.6

0.49

4.4

0.71

5.2

1.42

4.8

1.07

5.3

1.39

5.0

1.08

5.4

1.48

4.9

0.99

4.5

0.22

3.9

0.04

77

11

82

11

112

10

119

9

119

18

130

17

135

16

143

17

139

16

146

18

163

9

167

9

7

0

19.8

2.28

24.3

2.71

28.2

3.36

33.6

3.85

37.4

5.94

61.25

10.91

114.00

25.01

116.75

20.65

198.00

0.71

143.00

22.40

228.25

45.45

179.25

25.01

263.50

40.25

211.25

40.66

308.25

51.78

275.75

68.59

431.75

3.39

1

-

1

-

2

-

4

-

2

-

4

-

3

-

5

-

3

-

4

-

3

-

4

-

(%)
PECO2
(%)
HR
(bpm)

48
(mL
kg
min-1)
PIAF
(L
min-1)
MBS
(0-10)

M, Mean, SD, Standard Deviation, PICO2, Percentage of Inspired Carbon Dioxide, PECO2, Percentage of Expired Carbon Dioxide, HR, Heart Rate, bpm, Beats per minute,
Oxygen Uptake, PIAF, Peak Inspiratory Air Flow , MBS, Modified Borg Dyspnoea Scale. Statistical significance (p<0.05).

,

4.2.1 Effects of phonic respiration (speech)
Multiple paired-samples t tests were conducted to compare PICO2 in the two
breathing conditions (no speech and speech) across the six exercise workloads (rest,
75 W, 100 W, 125 W, 150 W and 175 W) (alpha level was set to 0.05). Consistent
with the preliminary hypothesis, there was a significant difference in PICO 2 between
periods of speech and no speech at rest (t(32)=19.2, p=0.00), 75 W (t(19)=9.72,
p=0.00), 100 W (t(33)=14.8, p=0.00), 125 W (t(29)=12.3, p=0.00), 150 W
(t(13)=6.5, p=0.00) and 175 W (t(3)=7.50, p=0.01).
These results suggest that speech in fact does have an impact on CO 2 re-

Inspired Carbon Dioxide (%)

breathing in RPDs. These differences are visible in the following graph (Figure 4.2).

3.5

3

*

*

*

*

*

2.5
No Speech

2
1.5

Speech

1
0.5
0
Rest

75 W

100 W

125 W

150 W

175 W

Workload (Watts)

Figure 4.2 Mean and standard deviations of inspired carbon dioxide during speech
and no speech wearing a full face respiratory protective device. The
asterisk represents significant differences at each workload (p<0.05).

Speech increased PICO2 at any given workload, however, the highest mean PICO2
occurred at rest for both breathing conditions. At rest, PICO 2 dramatically increased
by 56% during speech compared to no speech (from 1.6% to 2.5% PICO2). In
addition, PICO2 appeared to reduce with increased workload. On average, PICO 2
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was 24% higher during speech at rest, than at end exercise for participants. Mean
resting and end exercise values for PICO2 are compared in Table 4.3.

Table 4.3 Mean carbon dioxide inspired at rest and end exercise for speech and no
speech
Rest
End Exercise
No Speech

Speech

No Speech

Speech

PICO2 (%)

1.6

2.5

1.1

1.9

SD

0.41

0.51

0.38

0.60

SD, Standard Deviation, PICO2, Percentage of Inspired Carbon Dioxide

4.2.2 Effects of oxygen uptake
CO2 re-breathing appeared to decrease as workload or
shows a decrease in PICO2 with increasing
was hypothesised that

increased. Figure 4.3

for both conditions. From this, it

, actually does not induce CO2 re-breathing and may very

well reduce PICO2.

Inspired Carbon Dioxide (%)

3.5
3
2.5
No Speech

2

Speech

1.5
1
0.5
0
7

20

24

28

34

37

Mean VO2 (ml/ kg/ min)

Figure 4.3 Mean and standard deviations of inspired carbon dioxide during speech
and no speech for mean oxygen uptake (
) at each workload
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4.2.3 Effects of gender
A total of eight females volunteered for the pilot study.

Half of the female

participants (n=4) failed the TSI Portacount fit test. Therefore only four females
were included in the analysis.

It appeared females had lower PICO2 for all

conditions, but the final sample size was too small to accurately support this
hypothesis. More research on females and their sensitivity to CO 2 re-breathing is an
important issue that needs further analysis.

4.2.4 Effects of expired carbon dioxide
Another problem that may contribute to CO2 re-breathing is PECO2. In Table 4.2
PECO2 is observed to rise with exercise workload. However, PECO2 appeared to be
lower during speech. As well, PECO2 appeared to vary between participants. For
instance, Figure 4.4 and 4.5 is a series of tracings of two participants breathing flow
curves as a function of time. One participant (Figure 4.4) PECO2 was relatively low
at 4.2% (no speech) and 4.1% (speech). The other participant (Figure 4.5) had
significantly higher PECO2 (above 7%). The participant with the higher PECO2
and maintained speech for longer.

200
100
0
-100

1
40
79
118
157
196
235
274
313
352
391
430
469
508
547
586
625
664
703
742
781
820
859
898
937
976
1015
1054

Flow Rate (L min)

appeared to have lower

-200
-300

Time (milliseconds)
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875
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951
989
1027

Flow Rates (L min)

400

-600
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0.4
0.2

-0.2

1
43
85
127
169
211
253
295
337
379
421
463
505
547
589
631
673
715
757
799
841
883
925
967
1009
1051
1093
1135

0

-0.4

Time (milliseconds)

1000
500
0
-500

1
42
83
124
165
206
247
288
329
370
411
452
493
534
575
616
657
698
739
780
821
862
903
944
985
1026
1067
1108

Flow Rate (L min)

Flow Rate (L min)

Figure 4.4 Sample breathing flow curves during no speech (top) and speech (below)
whose expired carbon dioxide was relatively low at 4.2%

Time (milliseconds)

Figure 4.5 Sample breathing flow curve no speech (top) and speech (below) whose
expired carbon dioxide was above 7%

4.2.5 Dyspnoea
Dyspnoea (MBS) scores during speech and no speech are shown in Table 4.2. The
relationship between PICO2 and dyspnoea was difficult to establish in this study.
MBS peak scores arose during end exercise and speech periods for participants, yet
end exercise generally had lower PICO2 on average. Other confounding factors that
may contribute to dyspnoea with this protocol include decreased inspiration time,
and VT during speech.
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4.2.6 Peak inspiratory air flow
PIAF in this study was calculated as the mean of all breaths during 30 seconds of
each measurement period and corrected to BTPS. The highest PIAF scores were
seen during speech (Table 4.2). The maximum mean PIAF was 431.75 L min-1
(SD=3.39) and occurred at 175 W during speech. Whereas the lowest mean PIAF
was 61.25 L min-1 (SD=10.91) occurred at rest and during no speech. PIAF was also
affected by exercise workload and increased by 77% when PIAF was compared at
rest (no speech) and at 175 W. It can be assumed higher flow rates affects PICO 2 by
aiding in the removal of PECO2 from the RPD.

4.2.7 Heart Rate
Speech appeared to have an impact on HR. HR was on average 6% higher during
speech than no speech. Yet, this difference decreased in magnitude with workload.
As PICO2 was generally higher during lighter workloads, this tends to support that
CO2 re-breathing increases HR.

4.3

Study Limitations

The pilot study allowed changes to the apparatus and procedures to be implemented
before the field study was conducted. The main modifications to the methodology
are summarised below.

4.3.1 Equipment modifications
Prior to the pilot study the apparatus was observed to have high variability in CO2
levels. Two compartments of water were used to collect samples of inhaled and
exhaled air (Figure 4.6). It was detected that the water was absorbing CO 2 from the
sampled air and was releasing this CO2 over time, which resulted in artificially high
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readings. The apparatus was subsequently modified so that inhaled and exhaled air
was sampled from rubber balloons. This set up can be observed in Figure 4.7.

Figure 4.6 Initial apparatus to collect separate gas
samples of expired and inspired air using
two compartments of water

Figure 4.7 The modified apparatus to collect
expired and inspired air samples
using rubber balloon mechanism
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In addition throughout the pilot study the CO2 analyser exhibited a slow upward drift
in readings. This was corrected by calibrating the apparatus immediately prior to
testing. The need to calibrate the rig before each test was an essential aspect of the
pilot procedure. It is noted that this limitation of the equipment may lead to some
variability or overestimation of CO2 re-breathing.

4.3.2 Procedural difficulties
It is worth noting nearly one in four participants did not meet the preferred inclusion
criteria of passing the TSI Portacount fit test (refer to Table 4.1). Despite few
significant differences found in PICO2 results for participants who passed or failed
the TSI Portacount fit test it is recommended that this is upheld as inclusion criteria
for the field study. This is because employees are required to pass fit tests before
they don RPDs in the workplace. The disadvantage to this procedure is that it adds
10-15 minutes to the length of the assessment process and decreases the sample size
for data analysis.

4.4

Summary

In summary, the practicability of performing the tests for the field study is high. The
benefit of conducting the pilot study was it allowed us to identify and overcome
possible errors that may limit data collection before moving onto the field study. The
pilot study supported the hypothesis that CO2 re-breathing increases during speech.
Since increased PICO2 necessitates increased VE,

, PECO2, dyspnoea and limits

exercise performance, speech may very well contribute to RPD discomfort and
reduce wear time. RPDs that are designed to permit speech and communication
should take these findings into consideration. Further analysis of CO2 re-breathing in
RPDs and its impact on workers who inevitably wear them for prolonged periods is
warranted.
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THE FIELD STUDY

From the pilot study it was hypothesised that speech and low exercise workloads
would contribute to CO2 re-breathing in RPDs. A larger sample size was required in
the field study so that the interaction of BSA, gender and age could be thoroughly
investigated. The results of the field study are provided in the following sections.

4.5

Participants

A total of 46 participants (one female) trained in the use of RPDs, volunteered for the
field study.

Of this sample, 13% (n=6) did not meet the selection criteria for

inclusion into the study, leaving a total of 40 participants. Five participants were
excluded from participation at the level of the PAR-Q form and one due to
equipment failure. All participants passed fit testing (>500 protection factor) with
the large S.E.A full face mask.
The ages of the participants ranged from 19 to 58 years, with a mean age of
35 (SD=±9.5). The majority of these participants were non smokers (n=32) and 55%
(n=22) reported that they were physically active or exercised on a regular basis.
State and trait anxiety scores were converted into percentile scores for a
normal adult population. The mean was 28% for state (participants anxiety at the
moment of testing) and 40% for trait (participants anxiety proneness).

No

participants were identified with severe or clinically severe levels of state or trait
anxiety, which was an additional exclusion criterion. Table 4.4 provides information
on the participants characteristics.

Table 4.4 Characteristics of the field study participants
Mean Median Minimum Maximum
Age (years)

35

34

19

58

Weight (kg)

91.7

89.5

58

128

56

Height (m)

1.79

1.77

1.67

1.92

BSA (m2)

2.09

2.09

1.67

2.41

State anxiety score (%)

28

20

2

88

Trait anxiety score (%)

40

39

2

87

Gender

1 female, 39 males

Kg, Kilogram, m, Metre, m2, Metre Squared, BSA, Body Surface Area

Testing was undertaken in an air conditioned room maintained at 24°C and 40%
relative humidity. The duration that participants were able to complete the exercise
assessment varied from 8-22 minutes. The sample varied in fitness, gender and
BSA, therefore 22 participants (55%) were administered the high level exercise
protocol and 18 completed the low level assessment. Within this, 12 participants
(30%) did not reach 85% of their maximal HR. Reasons to stop the exercise test
before target HR was reached included lower limb fatigue (n=6), end of exercise
protocol (n=3), dyspnoea (n=2) and general fatigue (n=1). Post assessment, all
participants reported speech contributed to dyspnoea while wearing the RPD. Unlike
the pilot study no participants experienced high PECO 2 beyond 7% or described
symptoms of headache, blurred vision or dizziness. This suggests trained users of
RPDs may have decreased sensitivity to CO2. Figure 4.8 is a flow chart of the study
cohort.
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All participants
recruited for the
field study
(n = 46)

Participants
excluded

Primary Analysis
(n=40)

(n=6)

Rest
(n=40)

75 Watts
(n=19)

100 Watts
(n=40)

125 Watts
(n=36)

150 Watts
(n=22)

175 Watts
(n=4)

Figure 4.8 Flowchart of field study participants

4.6

Results

The results of the field study for both breathing conditions (speech and no speech)
are displayed in Table 4.5. Generally data for all 40 participants was reported on, but
two data sets at rest and 100 W was disregarded due to inconsistency regarding
speaking during a no speech stage. The mean (M) and standard deviations (SD) for
all the parameters measured at rest and different workloads were compared. The
recorded outcome parameters included percentage of inspired CO2 (PICO2),
percentage of expired CO2 (PECO2), heart rate (HR), breathing frequency ( ), peak
inspiratory air flow (PIAF), dyspnoea (MBS) and oxygen uptake (

).

The

outcome measures were calculated across all six workloads (rest, 75 W, 100 W, 125
W, 150 W and 175 W) and the two breathing conditions (speech and no speech).
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Table 4.5 Effects of speech on respiratory parameters during rest and exercise wearing a full face respiratory protective device
Rest

75 W

100 W

125 W

150 W

175 W

(n=40)

(n=19)

(n=40)

(n=36)

(n=22)

(n=4)

No Speech

59

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

No Speech

Speech

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

PICO2
(%)

1.52

0.38

*2.10

0.47

1.20

0.21

*1.50

0.36

1.16

0.26

*1.57

0.36

1.05

0.20

*1.46

0.37

0.96

0.19

*1.36

0.32

1.01

0.27

1.43

0.17

PECO2
(%)

3.87

0.38

3.82

0.42

4.82

0.47

4.70

0.56

4.80

0.54

4.60

0.46

4.79

0.44

4.56

0.49

4.63

0.46

4.44

0.67

4.74

0.31

4.56

0.23

HR
(beat
min-1)

82

12

84

14

112

15

116

16

121

13

125

16

134

14

137

14

144

10

146

10

150

9

157

9

17

5

13

4

21

5

18

4

22

6

19

5

25

5

21

5

26

6

24

5

26

4

26

4

O2
(mL-kg
min-1)

7.0

0

-

-

18.8

1.51

-

-

21.6

2.18

-

-

25.3

2.75

-

-

28.7

3.32

-

-

33.2

4.01

-

-

PIAF
**
(L min1
)

80.50

15.89

*125.75

30.77

150.00

15.01

*225.00

28.87

172.75

20.47

*247.25

27.18

201.50

20.02

*268.75

25.75

232.25

30.84

305.25

35.52

227.75

31.79

*323.50

46.42

0

-

0.5

-

1

-

2.5

-

2

-

3

-

3

-

4

-

4

-

4.5

-

3

-

5

-

(breaths
min-1)

MBS
(0-10)

M, Mean, SD, Standard Deviation, PICO2, Percentage of Inspired Carbon Dioxide, PECO2, Percentage of Expired Carbon Dioxide, HR, Heart Rate,

, Breathing Frequency, PIAF,

Peak Inspiratory Air Flow , MBS, Modified Borg Dyspnoea Scale, BTPS, Body Temperature & Pressure Saturated. *Statistical significance (p<0.05) from paired samples t-test.
**PIAF is in BTPS and rounded to the nearest 0.25

4.6.1 Effects of phonic respiration (speech)

Speech significantly elevated the levels of CO2 re-breathed inside the RPD. The
mean level of PICO2 during speech was (mean±SD) 2.1±0.47%, 1.5±0.36%,
1.6±0.36%, 1.5±0.37%, 1.4±0.32% and 1.4±0.17% for the period of Rest, 75 W, 100
W, 125 W, 150 W and 175 W respectively. In the same order the mean PICO2
attained during no speech was 1.5±0.38%, 1.2±0.21%, 1.2±0.26%, 1.1±0.20%,
1.0±0.19% and 1.0±0.27% (refer to Table 4.6).
Multiple paired-samples t tests were conducted to compare PICO2 that
occurred in the two breathing conditions (no speech and speech) across all six
exercise workloads (rest, 75 W, 100 W, 125 W, 150 W and 175 W) (alpha level was
set to 0.05). Consistent with the pilot results, there was a significant difference in
PICO2 between periods of speech and no speech at rest (t(38)=7.75, p=0.00), 75 W
(t(18)=6.07, p=0.00), 100 W (t(35)=6.07, p=0.00), 125 W (t(33)=6.57, p=0.00), and
150 W (t(11)=4.90, p=0.00). Although there was a weak relationship at 175 W, it
did not achieve significance (t(3)=2.93, p=0.06) (refer to Figure 4.9).

Table 4.6 Mean carbon dioxide inspired at rest and exercise for conditions of no
speech and speech
No Speech
Speech
M
SE
M
SE
t
df
Rest
1.5
0.06
2.1*
0.08
7.75
38
75 W
1.2
0.03
1.5*
0.06
6.07
18
100 W
1.2
0.04
1.6*
0.06
6.07
35
125 W
1.1
0.03
1.5*
0.06
6.57
33
150 W
1.0
0.03
1.4*
0.05
4.90
11
175 W
1.0
0.04
1.4
0.03
2.93
3
M, Mean, SE, Standard Error of the Mean. Note. *=Statistical significance (p≤0.05) from paired samples
t-test.
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1.5
Speech

1
0.5
0
Rest

75 W

100 W

125 W

150 W

175 W

Workload (Watts)

Figure 4.9 Mean and standard deviations of inspired carbon dioxide during speech
and no speech wearing a full face respiratory protective device. The
asterisk represents significant differences at each workload (p<0.05).

Speech increased PICO2 during rest and exercise. The highest percentage change for
PICO2, between speech and no speech occurred at 175 W.

PICO 2 increased

considerably by 42% during speech at 175 W (from 1.0% to 1.4% PICO2). The
highest mean PICO2 occurred at lower workloads for both breathing conditions. On
average, PICO2 was 32% higher during speech at rest, than at end exercise for
participants. Mean resting and end exercise values for PICO 2 are compared in Table
4.7.

Table 4.7 Mean carbon dioxide inspired at rest and end exercise for speech and no
speech
Rest
End Exercise
No Speech

Speech

No Speech

Speech

PICO2 (%)

1.5

2.1

1.0

1.4

SD

0.38

0.54

0.16

0.37

SD, Standard Deviation, PICO2, Percentage of Inspired Carbon Dioxide

Some participants PICO2 exceeded 3% during speech at rest. For example, PICO2
reached a maximum of 3.5% in one participant.
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Figures 4.10 to 4.12 shows

breathing flow data of three participants with 3% PICO2 or greater. None of these
participants reported symptoms connected to CO2 re-breathing (nausea, headache or
dizziness). In two of the three participants, speech caused a reduction in respiration
by reducing

by almost 20%. The third participant (Figure 4.12) had a

of nine

breaths per minute which was 50% lower than baseline.
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Figure 4.10 Breathing flow data for one participant with inspired carbon dioxide as
high as 3.0% during rest and speech

Time (milliseconds)

Figure 4.11 Breathing flow data for one participant with inspired carbon dioxide as
high as 3.1% during rest and speech
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Figure 4.12 Breathing flow data for one participant with inspired carbon dioxide as
high as 3.5% during rest and speech

For two participants observed to have the lowest PICO 2 at rest and during speech
(1.3%) their breathing patterns appeared to be inconsistent with others. One
participant’s

was 25% higher during speech.

The other participant’s

was

observed not to change with or without speech (18 breaths per minute, 30% higher
than the average).
In summary, PICO2 levels during no speech and work was always below 2%.
However, an elevation in PICO2 above 2% occurred for several participants during
speech at 75 W (n=2), 100 W (n=6) and 125 W (n=3). Therefore, the results of the
field study support the findings from the pilot study that suggest PICO2 is
significantly elevated during periods of speech in RPDs.

4.6.2 Effects of oxygen uptake

The field study also aimed to determine the impact of metabolic workload on CO2 rebreathing. The mean

values for rest and each exercise workload is displayed in

Table 4.2. The highest mean

was 33.15 ml kg min-1 and gave rise to 1.0% (no

speech) and 1.4% (speech) PICO2. Additionally the minimum PICO2 was 0.6% and
was obtained at this work rate. The results obtained showed that higher O2 levels
resulted in the decline of PICO2. Figure 4.13 shows a negative trend in PICO2 with
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increasing

for both conditions. Hence it was hypothesised that increased

,

may very well reduce PICO2 in RPDs.
To evaluate this prediction, linear mixed model analysis was conducted to
assess the effects of O2 and the experimental conditions, speech and no speech, on
PICO2. There were five levels of

corresponding to the following groups: rest

(n=40), 75 W (n=19), 100 W (n=40), 125 W (n=36) and 150 W (n=22). Note that
175 W was not tested due to unsatisfactory sample size. Statistical significance was
set at an alpha level of 0.05.
Without speech, the effect of O2 on PICO2 was significant, F (1, 4)=19.8,
p=0.00. Similarly, interactions between speech and

O2 had significant effects on

PICO2, F (1, 4)=25.7, p=0.00. Post-hoc tests were conducted to examine all pairwise
contrasts using the Bonferroni adjustment.

Since this involved five pairwise

contrasts for each workload (excluding 175 W due to small sample size) the critical
alpha level to be used for these contrasts was 1/5 times 0.05, that is, a critical  of
0.2. Of the five contrasts without speech, level one (rest) differed significantly from
all others and level 5 (150 W) differed significantly from level 1 (rest) and level 3
(100 W). However, level 2 (75 W) did not differ significantly from 3 (100 W) or 4
(125 W) (p<0.05). Similarly during speech, level one (rest) differed significantly
from all others. Level 3 (100 W) did not differ from level 2 (75 W), level 4 (125 W)
and level 5 (150 W). This reflects that CO2 re-breathing is reduced significantly once
a higher

O2 is obtained with exercise. However, the difference between PICO2

against small increments in

is less significant.

64

Inspired Carbon Dioxide (%)

3
2.5

*

*

*

*

*

2

No Speech

1.5

Speech

1
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0
7

17.9

21.1

24.6

Mean VO2 (ml kg

27.5

33.2

min-1)

Figure 4.13 Mean and standard deviations of inspired carbon dioxide for oxygen
uptake (
) during both speech and no speech. The asterisk represents
significant differences at each workload (p<0.05).

4.6.3 Body surface area
Participants were categorised into groups based on their calculated BSA (small:
BSA≤1.70 m2; medium: 1.70 m2<BSA≤1.90 m2; large: BSA>1.90 m2). The goal
was to recruit a wide range of persons representing three body sizes (small, medium
and large), however 35 participants (88%) fell into values for a person with a large
BSA (>1.9 m2). The mean BSA was 2.08 m2 and only five participants (13%) had a
BSA between 1.7 m2 and 1.9 m2 (medium body size). Therefore, analysis of BSA
and PICO2 were limited to these two categories.
An independent t test was conducted on PICO2 values, with α at 0.05, to
determine if BSA influenced the data. The mean PICO2, PIAF,

and for both

medium and large BSA is displayed in Table 4.8.
Assumptions of normality and homogeneity of variance was met for both test
conditions (no speech and speech) at rest. The t test results indicated that there was
not a statistically significant difference in the PICO 2 levels between the medium
BSA, no speech group (M=1.48, SD=0.31) and large, no speech group (M=1.52,
SD=0.39) conditions t(37)=0.25, p=0.80. Similarly no significant differences were
revealed for PICO2 levels between the medium BSA, speech group (M=1.98,
65

SD=0.44) and large, speech group (M=2.12, SD=0.48) conditions t(38)=0.58,
p=0.72.
At 75 W, a weak relationship between the medium BSA, no speech group
(M=0.89, SD=0.01) and large BSA, no speech group (M=1.16, SD=0.19) was found
however, it did not reach significance t(15)=2.00, p=0.06. There was a violation of
the assumption of homogeneity of variance at 75 W (speech) so the t test for unequal
variance was computed. The results indicated significant differences for PICO 2
levels between the medium BSA, speech group (M=1.18, SD=0.28) and large,
speech group (M=1.58, SD=0.35) conditions t(15)=4.32, p=0.00.
Assumptions of normality and homogeneity of variance was met for both test
conditions (no speech, speech) at 100 W. The t test results indicated that there was
not a statistically significant difference in the PICO 2 levels between the medium
BSA, no speech group (M=1.15, SD=0.27) and large, no speech group (M=1.16,
SD=0.26) conditions t(37)=0.13, p=0.90. Similarly no significant differences were
revealed for PICO2 levels between the medium BSA, speech group (M=1.70,
SD=0.60) and large, speech group (M=1.56, SD=0.34) conditions t(34)=0.74,
p=0.47.
Again, assumptions of normality and homogeneity of variance was met for
both test conditions (no speech and speech) at 125 W. The t test results indicated
that there was not a statistically significant difference in the PICO2 levels between
the medium BSA, no speech group (M=1.04, SD=0.26) and large, no speech group
(M=1.06, SD=0.19) conditions t(34)=0.12, p=0.88. Also, no significant differences
were revealed for PICO2 levels between the medium BSA, speech group (M=1.61,
SD=0.58) and large, speech group (M=1.44, SD=0.34) conditions t(32)=0.83,
p=0.42.
At 150 W assumptions of normality and homogeneity of variance was met for
both test conditions (no speech, speech). The t test results indicated that there was
not a statistically significant difference in the PICO 2 levels between the medium
BSA, no speech group (M=0.89, SD=0.33) and large, no speech group (M=0.97,
SD=0.18) conditions t(20)=0.56, p=0.59.

Also, no significant differences were

revealed for PICO2 levels between the medium BSA, speech group (M=1.32,
SD=0.36) and large, speech group (M=1.36, SD=0.33) conditions t(10)=0.19,
p=0.89.
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Lastly, at 175 W due to the small sample size tests for homogeneity of
variance could not be carried out. Overall, these results suggest that BSA may not
have an important affect on PICO2 in RPDs. However, at some workloads there did
appear to be a slight tendency for larger participants to have a greater level of CO 2 rebreathing. Future research will benefit from comparing PICO2 in small to medium
size wearers of RPDs.
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Table 4.8 Mean inspired carbon dioxide for medium (a) and large (b) BSA participants
(a) Mean Carbon dioxide inspired at rest and exercise for speech and no

(b) Mean Carbon dioxide inspired at rest and exercise for speech and no

speech tasks in medium BSA participants
Stage

Power

Oxygen

Output

Uptake

W
ml kg
min

-1

PIAF

PIAF

No
Speech
L min

-1

speech tasks in large BSA participants

PICO2

PICO2

Speech

No

L min-1

Speech

(BTPS)

Stage

Power

Oxygen

Speech

Output

Uptake

%

W

%

min

PIAF

-1

PICO2

PICO2

No

Speech

No

Speech

Speech

L min-1

Speech

%

-1

(BTPS)

%

L min

ml kg

(BTPS)

PIAF

(BTPS)

1(n=4)

0

7.0

61.13

99.25

1.5

2.0

1(n=35)

0

7

75.81

129.50

1.5

2.1

2(n=3)

75

21.0

135.40

248.5

0.9

*1.2

2(n=17)

75

17.6

138.29

222.25

1.1

*1.5

3(n=4)

100

25.0

139.80

227.75

1.2

1.7

3(n=32)

100

20.7

160.95

249.50

1.2

1.6

4(n=4)

125

29.5

166.88

248.75

1.0

1.6

4(n=30)

125

24.0

187.55

271.25

1.1

1.4

5(n=2)

150

34.3

200.85

306.0

0.9

1.3

5(n=10)

150

26.9

214.71

305.00

1.0

1.4

6(n=1)

175

38.2

190.30

292.0

1.0

1.6

6(n=3)

175

31.5

215.83

334.00

1.0

1.4

Percentage of Inspired Carbon Dioxide, PIAF, Peak Inspiratory Air Flow , W, Watts,VO 1, Oxygen Uptake, BTPS,

Percentage of Inspired Carbon Dioxide, PIAF, Peak Inspiratory Air Flow , W, Watts,VO1, Oxygen Uptake, BTPS,

Body Temperature & Pressure Saturated. *Statistical significance (p<0.05) from an independent t test

Body Temperature & Pressure Saturated. *Statistical significance (p<0.05) from an independent t test
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4.6.4 Effects of gender
Only one female participant was recruited for the field study. Again, it appeared
females had a lower PICO2 for most conditions.

However, a larger sample is

required to accurately support this hypothesis. More research on females and their
sensitivity to CO2 re-breathing is an important issue that needs further analysis.

4.6.5 Effects of expired carbon dioxide
Exhaled air was CO2 rich and generally ranged from 3-5% in the data. Despite
PICO2 highest at rest and during speech, PECO2 remained higher during periods of
work and in the absence of speech (see Figure 4.14). The maximum mean PECO2
was 4.82% and occurred at 75 W (no speech). The lowest mean PECO2 was 3.82%

Expired Carbon Dioxide (%)

and occurred at rest (speech).

6
5
4

No Speech

3

Speech
2
1
0
Rest

75 W

100 W

125 W

150 W

175 W

Workload (Watts)

Figure 4.14 Mean and standard deviations of expired carbon dioxide during exercise
for speech and no speech

Overall, the two highest PECO2 values was 5.8% and occurred at 75 W (speech) and
100 W (no speech). High PECO2 did not correspond with symptoms of hypercapnia
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(such as dyspnoea). Figure 4.15 and 4.16 reflects tracings of breathing flow curves
for both these participants. Once more, higher PECO2 appears to correlate with
and larger VT.
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Figure 4.15 Breathing flow data for one participant with expired carbon dioxide as
high as 5.8% at 75 W (speech)

Time (milliseconds)

Figure 4.16 Breathing flow data for one participant with expired carbon dioxide as
high as 5.8% at 100 W (no speech)

4.6.6 Dyspnoea
Dyspnoea (MBS) scores during speech and no speech are shown in Table 4.2. No
dyspnoea was reported during rest. However, dyspnoea was observed to rise during
both exercise and speech. PECO2 may be linked to dyspnoea, as PECO2 increased
with exercise. However, PECO2 appeared to be lower during speech, therefore, the
link between PCO2 and dyspnoea was difficult to establish in this study.
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4.6.7 Peak inspiratory air flow
PIAF in this study was calculated as the mean of all breaths during 30 seconds of
each measurement period. The highest PIAF scores were seen during speech (Table
4.2). The maximum mean PIAF was 323.50 L min-1 and occurred at 175 W during
speech. Whereas the lowest mean PIAF was 80.50 L min -1 occurred at rest and
during no speech.
Multiple paired samples t tests were conducted to compare PIAF and the two
breathing conditions (no speech and speech) across the six exercise workloads (rest,
75 W, 100 W, 125 W, 150 W and 175 W) (alpha level was set to 0.05). There was a
significant difference in PIAF between periods of speech and no speech at rest
(t(39)=-2.85, p=0.01), 75 W (t(34)=-5.27, p=0.00), 100 W (t(39)=-4.14, p=0.00),
125 W (t(39)=-4.47, p=0.00) and 175 W (t(39)=-2.05, p=0.047). Although there was
a weak relationship at 150 W, it did not achieve significance (t(39)=1.78, p=0.08).
These values are lower than those achieved in the pilot study signifying that trained
wearers of RPDs may have a greater tolerance for performing work in RPDs. PIAF
was also affected by exercise workload. For instance, PIAF increased by 77% from
rest (no speech) to 175 W (no speech). Given the lowest mean PICO2 readings
occurring at 175 W, it is possible higher flow rates aid in the removal of PECO 2 in
the RPD.

Table 4.9 Mean peak inspiratory air flow at rest and exercise for conditions of no
speech and speech
No Speech
Speech
M
SE
M
SE
t
df
Rest
80.50
2.51
125.75*
4.87
2.85
39
75 W
150.00
2.37
225.00*
4.56
5.27
34
100 W
172.75
3.24
247.25*
4.30
4.14
39
125 W
201.50
3.16
268.75*
4.07
4.47
39
150 W
232.25
4.88
305.25
5.62
2.05
39
175 W
227.75
5.03
323.50*
7.34
1.78
39
M, Mean, SE, Standard Error of the Mean. Note. *=Statistical significance (p≤0.05) from paired samples
t-test .
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4.6.8 Heart rate
Speech appeared to influence HR. HR was on average 2.9% higher during speech
than no speech. Hence during speech WOB appears to be increased in RPDs. Yet,
this relationship appeared to decrease in importance as workload increased (175 W
excluded). These differences were less than the pilot study results (down from
5.5%). Again, this indicates that trained users in RPDs have adapted to performing
work in the device.

4.6.9 Breathing frequency
At rest, speech decreased

by 24%. There was a reduction in

workload except at 175 W, where

during speech and no speech was comparable

(refer to Figure 4.17). The maximum mean
(speech and no speech).

at every other

was 26 breaths·min-1 at 175 W
was 13 breaths min-1 at rest

The minimum mean

Breathing Frequency (breath/ min)

(speech).

50
45
40
35
30

No Speech

25

Speech

20
15
10
5
0
Rest

75 W

100 W

125 W

150 W

175 W

Figure 4.17 Mean and standard deviations for breathing frequency during rest and
exercise for speech and no speech
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5 DISCUSSION AND CONCLUSION

5.1

Summary

Overall, the aim of this study was to evaluate the level of CO 2 re-breathing that
occurs in RPDs. From the literature reviewed it was clear that a number of factors
are already associated with CO2 re-breathing in RPDs including, mask dead space,
breathing resistance, work rate, RPD type and the size of person (ISO/TS16976-3:
2011). However, it was evident that little research has been conducted to evaluate
the impact of speech on CO2 re-breathing.

Given that many occupations (for

example, fire fighting, construction work and health care workers) require the use of
RPDs as well as communication in the workplace this research provides more
information in the use of RPDs in such situations.
Therefore, this study specifically looked at the impact of speech and various
work rates on CO2 re-breathing in RPDs. A protocol to test the level of CO2 inspired
during both speech and no speech was developed. Additionally, an apparatus was
designed to collect both expired and inspired CO2 samples and physiological
parameters during a graded exercise test on a bicycle ergonometer. A pilot study
provided an opportunity to test the assessment process with a group of volunteers
before conducting the field study. Following this, a field based study was carried out
to assess the levels of CO2 re-breathing in workers trained in the use of RPDs.
From the results, it can be seen that PICO2 in RPDs is elevated during speech.
Additionally, mean PICO2 appeared to reduce as exercise workload increased, to the
point that there was minimal to no difference in PICO2 at 175 W. A correlation with
and reduced PICO2 was also found for both breathing conditions (speech and no
speech) at each exercise stage (except 175 W). Differences in PICO2 between gender
and BSA were not found.

It was concluded that speech and low work rates

contributed significantly to CO2 re-breathing in RPDs.
The implication of this research is that CO2 re-breathing in RPDs may be
associated with wearer discomfort and may be linked with reduced wear time. The
finding that PICO2 is significantly elevated during speech is important as majority of
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workers are required to communicate while wearing RPDs in the workplace. This
knowledge will have an important impact on the use of RPDs.

5.2

Key Findings

Statistical analysis showed that both hypotheses were accepted. These key findings
will be discussed and related to previous research in the following sections.

5.2.1 Phonic Respiration (Speech)
Hypothesis one asked whether inspired CO2 in RPDs will vary significant during
speech. The answer is a qualified yes. These results confirm that speech interferes
with respiration in RPDs by increasing CO2 re-breathing. Results revealed speech
can contribute to CO2 surpassing current respirator design standards that specify
inspired CO2 should not exceed a maximum of 1% for more than one consecutive
minute when testing RPDs (AS/NZS 1716: 2003). This specification is also applied
in the Occupational Safety and Health Standards of OSHA: 1910.134 “Respiratory
Protection” and European Standards: EN 13274-6: 2002 for respirator classification.
To our knowledge this is a physiological burden for RPDs that has not been
highlighted in past research. However, the finding does align with the understanding
that if an individual does not breathe correctly (for example, hypoventilates),
hypercapnia will develop (Johnson et al. 2000, ISO/TS16976-3: 2011). This is the
situation during speech. Speech tends to markedly decrease

, inspiration time and

increase PIAF (Berndtsson 2004). Similar to others who have studied the effects of
speech on respiration, the findings of this study also suggest that speech decreases
(Doust and Patrick 1981, Baker et al. 2008). This also suggests speech produces a
reduction alveolar respiration without a change in metabolic rate which tends to
increase CO2 concentrations in RPDs (ISO/TS 16976-3:2011).
Increased PICO2 during speech was most likely the result of decreased
positive pressure and ventilation in the mask that occurs with speech.
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Speech

decreases inspiration time and

(Berndtsson 2004, Doust and Patrick 1981) which

is likely to decrease the influx of fresh air into the mask during the inspiratory phase
of breathing. This result over time may contribute to an accumulation of CO 2 in the
blood and elevate PECO2 and encumber breathing.
This current study demonstrates that periods of speech in RPDs cause an
increase in PICO2 well above the normal concentration found in atmospheric air
(0.03%) (Williams 2010).

PICO2 was as high as 3% (100 times atmospheric

concentrations) in some participants during periods of speech. In addition, almost
one in three participants inspired CO2 concentrations 2% or higher during periods of
speech at rest and low work rates. Participants with the highest PICO2 during speech
appeared to be those participants more prone to hypoventilation.

These PICO2

values are at a level that has been shown to have an impact on humans. For example,
a literature review by NIOSH (1976) indicates 1% inspired CO 2 is associated with
respiratory stimulation such as increased

, alveolar CO2 and

O2. A prolonged

exposure of 2% may also cause headache and dyspnoea (Stromberg and Eklund
1996). Moreover, 3% CO2 can increase VE by more than 35% (Takahashi et al.
2000).
The International Organization for Standardization (ISO) prepared a technical
report on the effects of hypercapnia and the impact of CO2 concentrations on
respirator use (ISO/TC 16976-3.2: 2010).

ISO (2010) specified that increased

concentrations of CO2 in the breathing space of a RPD may generate dyspnoea which
causes the user to remove the device. A clear causal relationship between PICO2 and
dyspnoea has been documented in past studies (Maresh et al. 1997). However, this
study could not make this link as speech, PICO2 and increases in exercise workload
contributed to feelings of dyspnoea. Also, it is unlikely that the wearer would
experience significant discomfort as elevated CO2 is only short-lived during speech.
However, repeated CO2 re-breathing (continuous speech) will lead to direct increases
in blood CO2 (McArdle, Katch and Katch 2001). In turn this will stimulate negative
physiological responses and cause discomfort, thereby impacting the wear time of
the device.
In summary, it appears little research has explored the impact of speech on
CO2 levels in RPDs. The findings of this study supported the initial hypothesis that
speech has a significant effect on CO2 re-breathing in RPDs. Given there are many
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occupations that require workers to communicate and wear RPDs in the workplace,
this research will have an important impact on the use of RPDs.

5.2.2 Oxygen Uptake (workload)
There has also been concern that exercise compounds CO 2 re-breathing in RPDs due
to increased metabolic production of CO2 (Williams 2010, ISO/TS16976-3: 2011).
During exercise there is a marked increase in

,

and PECO2 (McArdle, Katch

and Katch 2001, Brooks, Fahey and Baldwin 2005). The concern is that in a semi
closed or closed system, such as within a RPD, there is likely to be a build up of CO 2
(ISO/TS16976-3: 2011). If this extra CO2 was re-breathed by the wearer this may
very well lead to hyperventilation and dyspnoea and negatively impact work
performance.
In the current study PICO2 was shown to be inversely related to exercise and
lower work rates increased CO2 beyond recommended design limits (1%) (AS/NZS
1716: 2003). Therefore hypothesis two, which addressed whether CO2 re-breathing
would be influenced by

is also accepted. This data suggests that the large full

face S.E.A Pty Ltd Respirator became more efficient in the removal of dead space
CO2 at higher work rates. This is important as the metabolic production of CO 2
increases with exercise. These findings are consistent with other studies that found
PICO2 decreased with greater exercise efforts (Kloos and Lamonica 1966, Luria et al.
2004).
Factors that may influence these results include, flow rates during exercise
tend to increase (Berndtsson 2004). In turn, this would assist in ventilating mask
dead space and may explain decreased CO2 re-breathing at higher workloads. Luria
et al (2004) put forward that lower mask dead space during exercise may also lead to
this. In addition, fewer words were able to be spoken when exercise was imposed.
Therefore during high work rates and speech there is less interference in respiration
than at lower work rates and speech.
These findings may explain the unusual results of previous studies (Craig et
al. 1970 and Williams 2010) that demonstrated the greatest reduction in exercise
capacity in wearers of RPDs occurred at lower work rates. In addition, a recent study
by Roberge et al (2010) examined the physiological impact of N95 filtering face
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piece respirators. Ten adults (seven women) conducted two 60 minute treadmill
assessments at very low workloads walking at 2.74 km hr-1 (1.7 miles hr-1) and 4.02
km hr-1 (2.5 miles hr-1) while wearing the RPD. Data collected showed that deadspace CO2 ranged from 2.5-3.5% CO2 which is significantly above OSHA’s ambient
workplace standards. Roberge et al. (2010) concluded that even though the RPD did
not impose any significant physiological burden on participants, CO 2 retention was a
possibility due to elevated transcutaneous CO2 (equivalent to arterial CO2) levels.
On a similar note, although no symptoms of CO2 retention were recorded in this
study, the increases in CO2 during speech were sufficient enough to impact the
wearer.
Previous studies have stated that CO2 production is approximately 2.86 ml.kg 1

.min-1 at rest yet at moderate to heavy exercise may exceed 50 ml.kg-1.min-1

(Williams 2010). Therefore, contrary to our study others have reported that mean
PICO2 was not always highest at rest (Warkander and Lundgren 1995).
A potential reason for this discrepancy is exercise intensities were only set at
low to moderate workloads in this study. Therefore, the differences in PICO 2 at high
or maximal

cannot be compared and limits the interpretation of these results.

In summary, CO2 re-breathing in RPDs was shown to decrease during
increments in exercise workloads.

The above finding has implications for

individuals who are for the most part inactive and are required to wear RPDs in the
workplace.

There have been surprisingly few studies that have studied the

relationship between CO2 re-breathing and exercise workload in RPDs. Therefore
further research on this is important.

5.3

Study Limitations

In this study it should be noted that there were a number of limitations. It
was expected larger BSA participants would have a larger anatomical dead space and
as a result more likely to retain CO2 with each exhaled breath. In turn this would
return CO2 to the respiratory system with the next inhalation. However the current
study consisted of predominantly large BSA participants. Therefore, future studies
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of smaller BSA participants should be conducted to validate if BSA impacts CO 2 rebreathing in RPDs.
In addition, only one female participant was involved. A study on a larger
scale that included equal numbers of males and females would allow for the
physiological impact of CO2 re-breathing in females to be compared.
As mentioned, only low to moderate exercise intensities were assessed in this
study.

Therefore, exercise tests of high intensity where blood lactate (CO 2

production) is not linear with

and PaCO2 increases dramatically, will require

further analysis.
It is also important to note that one participant’s data was ineligible due to
technical problems with the equipment. A connection error between the DAQ board
and the bicycle ergonometer occurred. However, this was a single anomaly and was
resolved before further testing. See Figure 5.1 and 5.2 for an image of the apparatus
and bicycle ergonmeter set up for the field study.
Also, for the purposes of the TSI Portacount fit test the air conditioning vents
were obstructed during testing. This reduced room ventilation resulting in CO 2 build
up in the room air as high as 0.1%. However, following completion of the fit test the
room was aerated immediately before the exercise assessment process was
undertaken. This step appeared to aid in returning PCO2 to normal atmospheric
concentrations (0.03-0.04%),
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Figure 5.1 The apparatus set-up

Figure 5.2 Participant seated on the bicycle ergonometer

Another potential limitation in this research is that participants varied in the way they
read each passage. Hoit and Lansing (2007) also agreed with these observations.
For instance, some participants paused often, speaking fewer words.
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Other

participants paused occasionally, speaking more words during speech. Furthermore
although participants were encouraged not to speak in the no speech stages of testing,
a number of participants spoke briefly during this period. Lastly, some participants
finished talking in advance of the measurement process being complete. According
to Doust and Patrick (1981) respiration in the first 15 seconds after the cessation of
speech is 114% of the mean value. This overshoot in respiration before analysis of
PICO2 was complete can be seen in Figure 5.3. These inconsistencies during testing
will impact the results.
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Figure 5.3 Overshoot in respiration following a period of speech

5.4

Recommendations for Future Research

Recommendations for future research based on the findings of this study are as
follows:


Overall there was an underrepresentation of females and small to
medium BSA participants. To confirm if gender and BSA has an
impact on CO2 re-breathing a further study needs to be carried out. It
may be necessary to compare a small BSA or a predominantly female
group to this data.



This study compared PICO2 during a graded exercise test on a bicycle
ergonometer that was a maximum of 20 minutes in length. It would
be ideal to measure CO2 in RPDs during normal occupational
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activities using portable CO2 analysis equipment. This is due to the
intermittent nature of occupational activities.

In addition workers

often wear RPDs for several hours rather than 20 minute periods.
However, this mode of analysis is expensive and would require
technology and equipment not readily available. Hence, this could be
a future consideration for research investigating CO2 re-breathing in
RPDs.


Lastly, this study mainly looked at CO2 re-breathing during periods of
low to moderate work rates. However, it is well know that CO2
production dramatically increases during vigorous work rates group.
Hence further research is still needed to assess the impact of CO2 rebreathing at higher work rates.

5.5

Conclusion

In summary, this study established that there are significant increases in CO2 rebreathing in RPDs during periods of phonic respiration (speech) and low work rates.
It is worth noting that to our knowledge no previous investigations have evaluated
the impact of speech on PCO2 in RPDs. These results are particularly relevant to
occupations where employees are required to wear RPDs and communicate in the
workplace. Further research is still needed to assess the effects of gender and BSA
on CO2 re-breathing in RPDs. It is recommended that the findings in this study be
considered in the future design and use of RPDs. In addition workers using RPDs
should be aware of the physiological problems created by speech.
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Table 5.1 Literature review of carbon dioxide re-breathing in respiratory protective devices and the variables measured
Reference

Year

Journal

N

PICO2 (%)
Rest
1.3 ±0.7

PICO2 (%)
Work
1.0 ±0.3

Arad

1992

Chest

10

PAPR ±
Blower

TM

Capnograph, Pressure
Transducer

Bishop

1999

12

LES with
helmet visor

Walk

Craig

1970

Aviation Space
and Environmental
Medicine
Journal of Applied
Physiology

-

-

4

12

M9 protective
mask

TM

Infrared, pneumotachometer,
Strain gauge

-

3.1-3.9*

Fletcher

2006

Anaesthia

4

Technol
fluidshield
PFR 95
Modified M17
air-purifying
full face piece
Loads to
simulate a
RPD
Loads to
simulate a self
rescuer

Pre and Post
Procedure

Capnometer

-

-

Johnson

2000

13

Harber

1982

American
Industrial Hygiene
Association
Journ. Of Occup.
Med.

TM

Mass spectrometer,
pneumotachometer, pressure
transducer
Pneumotachometer,
Spirometer, Pressure
transducer, ECG
Katharometer, Pressure
transducer,

-

-

VO2, HR, BP, RPE, BAC,
TC, , STAI, blood pH,
lactate, SpO2, PCO2,
, TI, ET, TT, IE, IT, VE,
VT, PP, PIAF, HR

Love

1979

Ann. Occup. Hyg.

80

2,3, 4 & 5*

-

-

Head helmet

Rest

2.2±0.8

-

VO2, PICO2, PECO2,
PACO2*, FEV1, FVC,
MBC, VE, Vl, VT, DI, ,
RQ
PICO2, PETCO, VE, VI

Mojoli

2008

Roberge

2010

Intensive Care
Med
Respiratory Care

10

N95 FFR (2)

TM

2.0±0.3;
3.1±0.2**

3.0±0.3;
3.2±0.5**

HR, , VT, VE, SpO2,
PETCO2, MBS, RPE

9

RPD

Mode

Equipment

B

TM

BMS, Flow meter
(pneumotachometer)
Plethysmograph, CO2/O2
sensor model, Radiometer,
Portacount

89

-

Variables
HR, PIO2, PICO2, PEO2,
PECO2, , PIAF, PEAF,
Duty Cycle
PICO2, metabolic rate, VO2

MVV, HR, VT, ,TI, TE,
VO2, PICO2, PO2,, PECO2,
PIAF, TI, TE,
PETCO2, RPE

Luria

2004

Sinkule

2004

Stromberg

54

ACBS &
CETER
APEHR (A, B
& C)

TM

Infrared

-

TM

-

-

2.3±0.46;
1.3±0.35
-

Mass spectrometer,
plethysmograph,
pneumotachometer
Gas analysers,
pneumotachometer, pressure
gage
Mass spectrometer, Borg
Scale, Validyne Pressure
Transducer, Douglas bag, FM
recorder,
Pressure transducer, mass
spectrometer, diaphragmatic
electromyogram

0.84± 0.35

0.96±0.23

PICO2,PETCO2, Vd, VT, Vi,
HR, ECG

3% *

3%*

VE, PETCO2

0.29±0.06;
0.73±0.11;
1.19±0.16

0.23±0.01;
0.61±0.09
0.90±0.15

VE. PETCO2, PCO2, , VT,
VD, avCO2in, PmI, PmE,
RPE

-

-

PETCO2, VE, VA, VT, ,
MVV, FEV1, VC, ERV,
TI/TTIOT, VO2, RQ, WOB/V
Pmin, Pmax, HR Dyspnoea

7

1996

Medicine &
Science in Sports
& Exercise
Ergonomics

8

Welding visors
(7)

B

Takahashi

2000

J Occup Health

12

FFR

B

Warkander

`1995

Ergonomics

5

SCBA (3)

B

Warkander

1992

Undersea
Biomedical
Researh

6

SCBA

B
(immersed)

90

FICO2, HR
PICO2, PIO2

* CO2 was administered to subjects
** Mixed inspired/expired CO2
Nomenclature:
ACBS
Armoured vehicle crewmember
blower system
APEHR
Air purifying escape hood
respirator
avCO2, in
Average CO2 inspired
B
Bike
BAC
Breathing apparatus comfort
BL
Blood lactate
BMS
Body and metabolic simulator
CCBA
Closed circuit breathing apparatus
CETER
Chemical team respirator
DI
Dyspnoeic index = VE/MBC
Breathing frequency
ECG
Electrocardiogram
FEV1
Forced expiratory volume in 1s
FFR
Filtering face piece respirator
FVC
Forced vital capacity
HR
Heart rate
IE
Inspiratory: Expiratory Time

LES
MBC
MVV
PACO2
PAPR
PECO2
PETCO2
PIAF
PEAF
PICO2
PIO2
Pm, in
Pm, ex
PP
PCutCO2
RQ

Launch entry suit
Maximum breathing capacity
Max voluntary ventilation
Partial pressure of CO2 in
alveolar air
Powered air purifying respirator
Partial pressure of CO2 in expired
air
End Tidal PCO2
Peak inspiratory, flow rate
Peak expiratory, flow rate
Partial pressure of inspiratory
CO2
Partial Pressure of Inspired O2
Inspiratory mask pressure
Expiratory mask pressure
Peak mouth pressure
Transcutaeous CO2
Respiratory Quotient
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RPE
spO2
STAI
TC
TI
TE
TT
TLC
TM
VE
VI
VCO2
Vd
VO2
VT
VT

Rating of perceived exertion
Blood oxygen saturation
Speilberger state trait anxiety
inventory
Thermal comfort
Inspiratory time
Expiratory time
Total respiratory cycle time
Total lung capacity
Treadmill
Expiratory minute volume
Inspiratory minute volumes
CO2 production per minute
Dead Space
O2 uptake per minute
Tidal volume, volume per breath
Ventilatory
threshold
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PARTICIPANT INFORMATION SHEET FOR THE PILOT STUDY
TITLE: The CO2RE Project- The Impact of Carbon Dioxide (CO2) Re-Breathing in
Respiratory Protective Devices.
PURPOSE OF THE RESEARCH:
Measure the level of Carbon Dioxide (CO2) re-breathed (inhaled) in Respiratory
Protective Devices (RPDs).
Assess the physical demands this places on the wearer, especially in relation to
breathing.
Use this information to help manufacturers develop RPDs that are safe and more
comfortable to use in the workplace.

INVESTIGATORS:
Carmen Smith
(Principal investigator)
School of Health Sciences

Jane Whitelaw
(Supervisor)
School of Health Sciences

A/Prof Brian Davies
(Supervisor)
School of Health Sciences

cs847@uowmail.edu.au

jane_whitelaw@uow.edu.au

brian_davies@uow.edu.au

THE EXERCISE TEST: If you choose to be included in the Pilot Project, you will be
asked to participate in an exercise test on a bike wearing a RPD. Before the exercise test
commences you will be screened to ensure there are no health risks associated with
increasing your activity levels. Following this the researcher will take the time to fit you
with an appropriate sized RPD (large or small). The exercise test will begin at low level
and will be advanced in 5 minute stages by increasing pedal resistance. During the third
minute of each stage you will be asked to read aloud from a prepared text. You will be
asked to continue talking for one minute. Your heart rate, rating of breathlessness,
breathing responses and level of inhaled CO2 will be monitored continuously during the
exercise test. We wish to stop the test after 17-21 minutes of exercise. However, we
may stop the test at anytime due to fatigue or any symptoms you may experience. The
appointment will require about 45 minutes of your time. It is important you know this
project is completely voluntary. You have the right to request the test to be stopped at
any stage, decline to answer specific questions and/or withdraw data from the study at
any stage.
POSSIBLE RISKS AND DISCOMFORTS: There are certain discomforts associated
with wearing a RPD. These include increased breathing discomfort, heat buildup,
interference with vision and difficulty communicating. Also, it is important you

95

understand that there are a number of changes that may occur during exercise, such as
irregularities in heart rate, abnormal blood pressure response and in extremely rare
instances heart attack or death. Every effort will be made to minimise these risks by
providing appropriate supervision during the test. In addition compensation will be
provided to research participants if temporary or permanent injury occurs due to
participation in the research.
FUNDING AND BENEFITS TO BE EXPECTED: The Principal Investigator (PI) is
a Master Degree candidate in the School of Health Sciences at the University of
Wollongong. PI Smith has been granted the Safety Equipment Australia (S.E.A)
scholarship which amounts to a total sum of $35, 000. Your participation in The CO 2RE
Project will play a significant role in the understanding of how the level of carbon
dioxide in respirators influences the wearer. This will help manufacturers in the design
of more comfortable RPDs and assist with improving respiratory protection in the
workplace.
CONFIDENTIALITY:
All information collected will be coded to provide
confidentiality. The data will be stored in a locked file in a secure place or a password
protected database when not I use by the University of Wollongong. Information
gathered in this appointment will be used solely for statistical analysis, research articles
and presentations. The only item that could identify participants would be the master
copy of the booking sheet which will have the code for linking individuals to their raw
data. Only the investigators named above will have access to the information. Under no
circumstances is any personal or sensitive information disclosed. The responses you
provide and the data collected will be deleted or shredded after a period of five years.
ETHICS REVIEW AND COMPLAINTS: This study has been reviewed by the
Human Research Ethics Committee of the University of Wollongong. If you have any
concerns regarding the way this research has been conducted, you can contact the UOW
Ethics Officer on (02) 4221 4457. Should there be any adverse effects by participation
all participants have access to compensation.
ANY QUESTIONS: If you have any questions about any of the procedures, please feel
free to ask us, we will gladly answer them.
Thank you for your interest in The CO2RE Project.
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PARTICIPANT INFORMATION SHEET FOR THE FIELD STUDY
TITLE: The CO2RE Project- The Impact of Carbon Dioxide (CO2) Re-Breathing in
Respiratory Protective Devices.
PURPOSE OF THE RESEARCH:
Measure the level of Carbon Dioxide (CO2) re-breathed (inhaled) in Respiratory
Protective Devices (RPDs).
Assess the physical demands this places on the wearer, especially in relation to
breathing.
Use this information to help manufacturers develop RPDs that are safe and more
comfortable to use in the workplace.
INVESTIGATORS:
Carmen Smith
(Principal Investigator)
School of Health Sciences

Jane Whitelaw
(Supervisor)
School of Health Sciences

A/Prof Brian Davies
(Supervisor)
School of Health Sciences

cs847@uowmail.edu.au

jane_whitelaw@uow.edu.au

brian_davies@uow.edu.au

THE EXERCISE TEST: If you choose to be included in The CO2RE Project, you will
be asked to participate in an exercise test on a bike wearing a RPD. Before the exercise
test commences you will be screened to ensure there are no health risks associated with
increasing your activity levels. Following this the researcher will take the time to fit you
with an appropriate sized RPD (large or small). The exercise test will begin at low level
and will be advanced in 5 minute stages by increasing pedal resistance. During the third
minute of each stage you will be asked to read aloud from a prepared text. You will be
asked to continue talking for one minute. Your heart rate, rating of breathlessness,
breathing responses and level of inhaled CO2 will be monitored continuously during the
exercise test. We wish to stop the test after 17-21 minutes of exercise. However, we
may stop the test at anytime due to fatigue or any symptoms you may experience. The
appointment will require about 45 minutes of your time. It is important you know this
project is completely voluntary. You have the right to withdraw your consent to
participate and/or data from the study at any stage.
POSSIBLE RISKS AND DISCOMFORTS: There are certain discomforts associated
with wearing a RPD. These include increased breathing discomfort, heat buildup,
interference with vision and difficulty communicating. Also, it is important you
understand that there are a number of changes that may occur during exercise, such as
irregularities in heart rate, abnormal blood pressure response and in extremely rare
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instances heart attack or death. Every effort will be made to minimise these risks by
providing appropriate supervision during the test. In addition compensation will be
provided to research participants if temporary or permanent injury occurs due to
participation in the research.
FUNDING AND BENEFITS TO BE EXPECTED: The Principal Investigator (PI) is
a Master Degree candidate in the School of Health Sciences at the University of
Wollongong (UOW). PI Smith has been granted the Safety Equipment Australia (S.E.A)
scholarship which amounts to a total sum of $35, 000.. Your participation in The CO2RE
Project will contribute to our understanding of how the level of carbon dioxide in
respirators influences the wearer. This information will help manufacturers to design
more comfortable RPDs and assist with improving respiratory protection in the
workplace.
CONFIDENTIALITY:
All information collected will be coded to provide
confidentiality. The data will be stored in a locked file in a secure place or a password
protected database when not in use by the UOW. Information gathered in this
appointment will be used solely for statistical analysis, research articles and
presentations. The only item that could identify participants would be the master copy
of the booking sheet which will have the code for linking individuals to their raw data.
Only the investigators named above will have access to this information. Under no
circumstances is any personal or sensitive information disclosed. The responses you
provide and the data collected will be deleted or shredded after a period of five years.
ETHICS REVIEW AND COMPLAINTS: This study has been reviewed by the
Human Research Ethics Committee of the UOW. If you have any concerns regarding the
way this research has been conducted, you can contact the UOW Ethics Officer on (02)
4221 4457. Should there be any adverse effects by participation all participants have
access to compensation.
ANY QUESTIONS: If you have any questions about any of the procedures, please feel
free to ask us, we will gladly answer them.
Thank you for your interest in The CO2RE Project.
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APPENDIX D INCLUSION AND EXCLUSION CRITERION
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INCLUSION CRITERIA

Clean shaven
Prior experience with respirators or use them routinely on the job
Pass Portacount test
Men and women between the ages of 18 and 69 years

EXCLUSION CRITERIA

Contraindications to exercise listed on the PARQ form

94 mmHg)
eak, read or write English
th

Percentile or above and/or history of problems with anxiety

or claustrophobia
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APPENDIX E APPOINTMENT CONFIRMATION LETTER
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Dear

Thank you for signing up to participate in The CO2RE Project. Your appointment
time is:
Date: DAY MONTH YEAR
Time: APPOINTMENT TIME
Place: LOCATION OF ASSESSMENT
With: Carmen Smith
In preparation for the exercise assessment, you will need to aware of a few steps:
On Assessment Day:
 Do not exercise on the day of your appointment
 Do not consume any alcohol, caffeine, cigarettes/cigars or ‘heavy’ meals for
3 hours prior to your appointment
 Bring comfortable sporting clothes and running shoes (shorts and loose fitting
top)
 Please be clean shaven and free of stubble
 It would be a good idea to complete:
(1) PARQ form
(2) Consent form
These documents make up an important part of the assessment.
Attend Your Appointment
Please arrive a little early and allow 45 minutes for the assessment
If you are running late or unable to keep this appointment please call us and let us
know.
Please note all information collected will be held in the strictest of confidence.
We look forward to seeing you and thank you for your participation.
Sincerely,

Carmen Smith
Email: cs847@uowmail.edu.au
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APPENDIX F CONSENT FORM
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CONSENT FORM
I have been given information sheet regarding the Impact of Carbon Dioxide (CO2) ReBreathing in Respiratory Protective Devices” and discussed the research project with
Carmen Smith who is conducting this research as part of a Masters of Science - Research
supervised by Jane Whitelaw in the Department of School of Health Sciences at the
University of Wollongong.
I have read and understood this document in its entirety and had all my questions
answered satisfactorily. I hereby consent to voluntarily participate in the test procedures
I will perform with full knowledge of the risk and benefits involved.
I understand that my participation in this research is voluntary, I am free to refuse to
participate and I am free to withdraw from the research at any time without penalty.
If I have any enquiries about the research, I can contact Carmen Smith on
and/or supervisor Jane Whitelaw on (
Alternatively if I have any
concerns or complaints regarding the way the research is or has been conducted, I can
contact the Ethics Officer, Human Research Ethics Committee, Office of Research,
University of Wollongong on 02 4221 4457.
By signing below I am indicating my consent to
 An exercise test on a bike wearing a respiratory protective device
 The assessment of the physical demands this places on my breathing responses
 The use of this information for improving the design and manufacture of
respirators
I understand that the data collected from my participation will be used solely for
statistical analysis, research articles and presentations and I consent for it to be used in
that manner.

Participant Signature
.......................................................................
Name (please print)
.......................................................................
Witness Signature
.......................................................................
Name (please print)
.......................................................................

104

Date
......./....../......

Date
......./....../......

APPENDIX G MODIFIED BORG SCALE OF DYSPNOEA
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Modified Borg Dyspnoea Scale
0

Nothing at all

0.5

Very, very slight (just noticeable)

1

Very slight

2

Slight

3

Moderate

4

Somewhat severe

5

Severe

Exercise Training Zone

6
7

Very severe

8
9
10

Very, very severe (almost maximal)
Maximal

Patient Instructions for Borg Dyspnoea Scale
“This is a scale that asks you to rate the difficulty of your breathing. It starts
at number 0 where your breathing is causing you no difficulty at all and
progresses through to number 10 where your breathing difficulty is maximal.
How much difficulty is your breathing causing you right now?”
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APPENDIX H TERMINATION CRITERIA
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GENERAL INDICATIONS FOR STOPPING AN EXERCISE TEST IN LOW
RISK ADULTS*



Onset of angina and angina like symptoms



Drop in systolic blood pressure of >10 mmHg from baseline blood pressure
despite an increase in workload



Excessive rise in blood pressure: systolic pressure > 250 mmHg or diastolic
pressure > 115 mmHg



Shortness of breath, wheezing, leg cramps, or claudication



Signs of poor perfusion, light headiness, confusion, ataxia, pallor, cyanosis,
nausea, or cold/clammy skin



Failure of heart rate to increase with increased exercise intensity



Noticeable change in heart rhythm



Subject requests to stop



Physical/verbal manifestations of severe fatigue, for example score 7 or
above on the Modified Borg Dyspnoea Scale



Failure of the testing equipment

Modified from ACSM (2006)
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APPENDIX I PHYSICAL ACTIVITY READINESS QUESTIONNAIRE
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APPENDIX J PRE-SCREENING QUESTIONNAIRE
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PRE SCREENING QUESTIONNAIRE

SUBJECT No:

AGE:

DOB:

GENDER: M/F

PHONE:

E-MAIL:

EMERGENCY CONTACT:

PHONE:

LUNGS
DO YOU HAVE ASTHMA OR OTHER LUNG DISEASE?
DO YOU CURRENTLY SMOKE OR QUIT SMOKING
WITHIN THE PREVIOUS 6 MONTHS?

YES

NO

YES

NO

YES

NO

YES

NO

YES

NO

PSYCHOLOGICAL CONDITION
HAVE YOU EVER HAD CLAUSTROPHBIA (FEAR OF
CLOSED PLACES) OR PROBLEMS WITH ANXIETY?
RESPIRATOR USE
DO YOU HAVE EXPERIENCE WITH THE USE OF
RESPIRATORS?
AEROBIC EXERCISE
ARE YOU INACTIVE? (I.E. YOU GET <30 MINUTES OF
PHYSICAL ACTIVTY ON AT LEAST 3 DAYS PER WEEK?

COMMENTS (IF YOU ANSWERED YES TO ANY OF THESE QUESTIONS
OR WOULD LIKE TO ADD SOMETHING ABOUT LUNG CONCERNS,
PLEASE LIST HERE.)
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APPENDIX K STATE TRAIT ANXIETY INVENTORY: FIVE SAMPLE
ITEM AND PERMISSION LETTER
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APPENDIX L THE RAINBOW PASSAGE
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THE RAINBOW PASSAGE
“When the sunlight strikes raindrops in the air, they act like a prism and form a
rainbow. The rainbow is a division of white light into many beautiful colours. These
take the shape of a long round arch, with its path high above, and its two ends
apparently beyond the horizon. There is, according to legend, a boiling pot of gold at
one end. People look, but no one ever finds it. When a man looks for something
beyond reach, his friends say he is looking for the pot of gold at the end of the
rainbow.”
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APPENDIX M PROMOTIONAL MATERIAL
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APPENDIX N RECRUITMENT SCRIPT
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DIALOGUE FOR RECRUITMENT DVD:
“Breathing it is something you do all the time. However, a respirator can change the
way we breathe normally. The University of Wollongong is currently recruiting
participants for The CO2RE Project. We are investigating if carbon dioxide rebreathing increases breathing effort in respirators during periods of work. If you are
interested in participating please contact us for more information.”
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APPENDIX O ASSESSMENT RECORD FORM
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